WO2016036834A1 - Dp5-enriched syrups - Google Patents

Dp5-enriched syrups Download PDF

Info

Publication number
WO2016036834A1
WO2016036834A1 PCT/US2015/048107 US2015048107W WO2016036834A1 WO 2016036834 A1 WO2016036834 A1 WO 2016036834A1 US 2015048107 W US2015048107 W US 2015048107W WO 2016036834 A1 WO2016036834 A1 WO 2016036834A1
Authority
WO
WIPO (PCT)
Prior art keywords
amylase
starch
cspamy2
syrup
amylases
Prior art date
Application number
PCT/US2015/048107
Other languages
French (fr)
Inventor
Floor Klaaske KOOY
Bart Christiaan KOOPS
Original Assignee
Danisco Us Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco Us Inc. filed Critical Danisco Us Inc.
Publication of WO2016036834A1 publication Critical patent/WO2016036834A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • CCHEMISTRY; METALLURGY
    • C13SUGAR INDUSTRY
    • C13KSACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K1/00Glucose; Glucose-containing syrups
    • C13K1/06Glucose; Glucose-containing syrups obtained by saccharification of starch or raw materials containing starch
    • CCHEMISTRY; METALLURGY
    • C13SUGAR INDUSTRY
    • C13KSACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K7/00Maltose

Definitions

  • compositions and methods relating to DP5-enriched specialty syrups prepared from starch substrates using a-amylases prepared from starch substrates using a-amylases.
  • the syrups have applications in the food and beverage industry.
  • Starch consists of a mixture of amylose (15-30% w/w) and amylopectin (70-85% w/w).
  • Amylose consists of linear chains of a-l,4-linked glucose units having a molecular weight (MW) from about 60,000 to about 800,000.
  • MW molecular weight
  • Amylopectin is a branched polymer containing a- 1,6 branch points every 24-30 glucose units; its MW may be as high as 100 million.
  • Sugars from starch usually in the form of concentrated dextrose (glucose) syrups, are currently produced by an enzyme catalyzed process involving: (1) liquefaction (dissolving and hydrolysis of starch with an a-amylase into dextrins having an average degree of polymerization of about 7-10, and (2) saccharification of the resulting liquefied starch (i.e. starch hydrolysate) with amyloglucosidase (also called glucoamylase or GA).
  • the resulting syrup has a high dextrose content.
  • Much of the glucose syrup that is commercially produced is subsequently enzymatically isomerized to a dextrose/fructose mixture known as isosyrup.
  • the resulting syrup may be fermented with microorganisms, such as yeast, to produce commercial products including ethanol, citric acid, lactic acid, succinic acid, itaconic acid, monosodium glutamate, gluconates, lysine, other organic acids, other amino acids, and other biochemicals, for example. Fermentation and saccharification can be conducted
  • ⁇ -amylases are endo-acting enzymes and have a minimum starch substrate length requirement.
  • a-amylases tend to produce a population of oligosaccharides of varying length and little glucose. These oligosaccharides are identified by the number of glucose residues they contain, also referred to as their degree of polymerization (DP).
  • oligosaccharides are more desirable than others.
  • oligosaccharides containing five glucose residues i.e., G5 or DP5
  • G5 or DP5 have been used as a nutrients for patients with renal failure and those in a state of calorie-deprivation.
  • DP5 is also used a substrate in commercially available a- amylase assays.
  • oligosaccharides products have been described (e.g., Okemoto, H. et al. (1986) Appl.
  • compositions and methods relate to DP5-enriched specialty syrups and a- amylases used to produce them. Aspects and embodiments of the compositions and methods are illustrated by the following separately- numbered paragraphs:
  • a non-naturally-occurring syrup produced from a starch substrate by incubation with an ⁇ -amylase comprising >30 DP5 and ⁇ 10 DP6 as fractions of total reaction products or DP6/DP5 ⁇ 0.30, DP3/DP5 ⁇ 0.70, and DP2/DP5 ⁇ 0.50.
  • the syrup of paragraph 1 has DP6/DP5 ⁇ 0.30.
  • the syrup of paragraph 1 has DP6/DP5 ⁇ 0.20.
  • the syrup of paragraph 1 has DP6/DP5 ⁇ 0.15.
  • the syrup of any of paragraphs 1-4 is produced by incubating a starch substrate in the presence of CspAmy2 ⁇ -amylase or a variant, thereof.
  • the syrup of paragraph 5 is produced by an a-amylase variant of CspAmy2 comprising a deletion of residues 178 and 179 or 180 and 181, using SEQ ID NO: 3 for numbering.
  • a method for producing a syrup from a starch substrate comprising incubating the starch substrate in the presence of an ⁇ -amylase capable of producing >30% DP5 and ⁇ 10% DP6 as fractions of total reaction products, or DP6/DP5 ⁇ 0.30, DP3/DP5 ⁇ 0.70, and DP2/DP5 ⁇ 0.50, in a period of 30 hours at pH 5.2 and 60°C.
  • the a-amylase is capable of producing a reaction product having a DP6/DP5 ⁇ 0.30 in a period of 30 hours at pH 5.2 and 60°C.
  • the ⁇ -amylase is capable of producing a reaction product having a DP6/DP5 ⁇ 0.20 in a period of 30 hours at pH 5.2 and 60°C.
  • the ⁇ -amylase is capable of producing a reaction product having a DP6/DP5 ⁇ 0.15 in a period of 30 hours at pH 5.2 and 60°C.
  • the starch substrate is a corn, cereal, grain, or tuber liquefact.
  • the starch substrate comprises from about 10% to about 40% dissolved solids.
  • the amount of a- amylase used is from about 0.001 to about 0.05 mg/g dissolved solids.
  • incubating the starch substrate in the presence of ⁇ -amylase is performed without the addition of calcium to the starch substrate.
  • incubating the starch substrate in the presence of CspAmy2 ⁇ -amylase or a variant, thereof, is performed at a pH ⁇ 7.0.
  • incubating the starch substrate in the presence of ⁇ -amylase is performed at a pH ⁇ 6.0.
  • the starch substrate is incubated in the presence of CspAmy2 ⁇ -amylase or a variant, thereof.
  • the ⁇ -amylase is a variant of CspAmy2 comprising a deletion of residues 178 and 179 or 180 and 181, using SEQ ID NO: 3 for numbering.
  • Figure 1 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with CspAmy2.
  • Figure 2 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with SPEZYME XTRA®.
  • Figure 3 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with SPEZYME ALPHA®.
  • Figure 4 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with SPEZYME FRED®.
  • Figure 5 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with OPTEVIASE® AA 56L.
  • Figure 6 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with PURASTAR® HP Am 5000L.
  • Figure 7 is a graph showing the relative amounts of DP5 produced over time following incubation of a starch substrate with CspAmy2, OPTEVIASE® AA 56L, or
  • Figure 8 is a graph showing the relative amounts of DP5, DP6, DP3 and DP2 produced over time following incubation with different amounts of CspAmy2.
  • ppm parts per million e.g., ⁇ g protein per gram dry solid
  • a-amylase or "amylolytic enzyme” refer to an enzyme that is, among other things, capable of catalyzing the degradation of starch
  • a-amylases are hydrolases that cleave the a-D-(l ⁇ 4) O-glycosidic linkages in starch.
  • a-amylases (EC 3.2.1.1; a-D- (l ⁇ 4)-glucan glucanohydrolase) are defined as endo-acting enzymes cleaving a-D-(l ⁇ 4) O- glycosidic linkages within the starch molecule in a random fashion yielding polysaccharides containing three or more (l-4)-a-linked D-glucose units.
  • the exo-acting amylolytic enzymes such as ⁇ -amylases (EC 3.2.1.2; a-D-(l ⁇ 4)-glucan maltohydrolase) and some product- specific amylases like maltogenic a-amylase (EC 3.2.1.133) cleave the polysaccharide molecule from the non-reducing end of the substrate, ⁇ -amylases, a- glucosidases (EC 3.2.1.20; a-D-glucoside glucohydrolase), glucoamylase (EC 3.2.1.3; a-D- (l ⁇ 4)-glucan glucohydrolase), and product- specific amylases like the maltotetraosidases (EC 3.2.1.60) and the maltohexaosidases (EC 3.2.1.98) can produce malto-oligosaccharides of a specific length or enriched syrups of specific maltooligosaccharides.
  • starch refers to any material comprised of the complex polysaccharide carbohydrates of plants, comprised of amylose and amylopectin.
  • the term includes plant- based materials such as grains, cereal, grasses, tubers and roots, and more specifically materials obtained from wheat, barley, corn, rye, rice, sorghum, brans, cassava, millet, milo, potato, sweet potato, and tapioca.
  • starch includes granular starch.
  • granular starch refers to raw, i.e., uncooked starch, e.g., starch that has not been subject to gelatinization.
  • monosaccharide refers to a carbohydrate that cannot be hydrolyzed to produce more simple sugars. Monosaccharides are also referred to as monosaccharide units, glucopyranose units, monomers, and residues.
  • oligosaccharide refers to a carbohydrate consisting of two to ten monosaccharide units.
  • polysaccharide refers to a carbohydrate consisting of more than 10 linked monosaccharide units.
  • a “syrup” is a liquid containing dissolved monosaccharides, oligosaccharides, and soluble polysaccharides.
  • total soluble sugars refers to all dissolved monosaccharides
  • total soluble sugars is synonymous with the term "total reaction products.”
  • a "non-naturally-occurring syrup” is a liquid containing dissolved monosaccharides, oligosaccharides, and soluble polysaccharides that is produced by the intentional addition of a-amylase to a starch composition.
  • Non-naturally-occurring syrups exclude syrups that occur in nature and do not involve the hand of man.
  • a "specialty syrup” is a syrup containing a specified relative amount of dissolved monosaccharide, oligosaccharide, and soluble polysaccharide components, for example, >30 DP5 relative to total soluble sugars, ⁇ 10 DP6 relative to total soluble sugars, or a specified ratio of DP5 to DP6, DP5 to DP3, and the like.
  • degree of polymerization refers to the number (n) of glucopyranose units in a given saccharide.
  • DPI the monosaccharides glucose and fructose.
  • DP2 disaccharides such as maltose and sucrose.
  • DP>10 refers to all soluble saccharides longer than DP 10 that can be measured by HPLC using the column and assay method specified in the Examples.
  • DE or “dextrose equivalent,” is defined as the percentage of reducing sugar, i.e., D-glucose, as a fraction of total carbohydrate in a syrup.
  • dry solids content refers to the total solids of a slurry in a dry weight percent basis.
  • slurry refers to an aqueous mixture containing insoluble solids.
  • minutes of secondary liquefaction refers to the elapsed time of from the start of secondary liquefaction.
  • wild-type refers to a naturally-occurring polypeptide that does not include a man-made substitution, insertion, or deletion at one or more amino acid positions. Reference to the wild-type polypeptide is understood to include the mature form of the polypeptide.
  • a "mature" polypeptide or variant, thereof, is one in which a signal sequence is absent, for example, cleaved from an immature form of the polypeptide during or following expression of the polypeptide.
  • variant refers to a polypeptide that differs from a specified wild-type, parental, or reference polypeptide in that it includes one or more naturally-occurring or man-made substitutions, insertions, or deletions of an amino acid. The identity of the wild-type, parental, or reference polypeptide or polynucleotide will be apparent from context.
  • specific activity refers to the number of moles of substrate that can be converted to product by an enzyme or enzyme preparation per unit time under specific conditions. Specific activity is generally expressed as units (U)/mg of protein.
  • performance benefit refers to an improvement in a desirable property of a molecule.
  • exemplary performance benefits include, but are not limited to, increased hydrolysis of a starch substrate, increased grain, cereal or other starch substrate liquefaction, improved oligosaccharide reaction product profile, improved viscosity reduction, increased thermal stability, increased storage stability, increased solubility, an altered pH profile, decreased calcium dependence, increased specific activity, modified substrate specificity, modified substrate binding, modified pH-dependent activity, modified pH-dependent stability, increased oxidative stability, and increased expression.
  • the performance benefit is realized at a relatively low temperature. In some cases, the performance benefit is realized at relatively high temperature.
  • recombinant when used in reference to a subject cell, nucleic acid, protein or vector, indicates that the subject has been modified from its native state.
  • recombinant cells express genes that are not found within the native (non- recombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature.
  • Recombinant nucleic acids differ from a native sequence by one or more nucleotides and/or are operably linked to heterologous sequences, e.g., a heterologous promoter in an expression vector.
  • Recombinant proteins may differ from a native sequence by one or more amino acids and/or are fused with heterologous sequences.
  • a vector comprising a non-native gene encoding an amylase is a recombinant vector.
  • recovered refers to a compound, protein (polypeptide), cell, nucleic acid, amino acid, or other specified material or component that is removed from at least one other material or component with which it is naturally associated as found in nature.
  • purified refers to material (e.g. , an isolated polypeptide, DP5, etc.) that is in a relatively pure state, e.g. , at least about 90% pure, at least about 95% pure, at least about 98% pure, or even at least about 99% pure.
  • thermostability refers to the ability of the enzyme to retain activity after exposure to an elevated temperature.
  • the thermostability of an enzyme is measured by its half-life (tl/2) given in minutes, hours, or days, during which half the enzyme activity is lost under defined conditions.
  • the half-life may be calculated by measuring residual a- amylase activity following exposure to (i.e. , challenge by) an elevated temperature.
  • amino acid sequence is synonymous with the terms “polypeptide.”
  • protein and “peptide,” and are used interchangeably. Where such amino acid sequences exhibit activity, they may be referred to as an "enzyme.”
  • enzyme The conventional one-letter or three-letter codes for amino acid residues are used, with amino acid sequences being presented in the standard amino-to-carboxy terminal orientation (i.e. , N ⁇ C).
  • expression refers to the process by which a polypeptide is produced based on a nucleic acid sequence.
  • the process includes both transcription and translation.
  • water hardness is a measure of the minerals (e.g. , calcium and magnesium) present in water.
  • a cultured cell material comprising an amylase refers to a cell lysate or supernatant (including media) that includes an amylase as a component.
  • the cell material may be from a heterologous host that is grown in culture for the purpose of producing the amylase.
  • Percent sequence identity means that a particular sequence has at least a certain percentage of amino acid residues identical to those in a specified reference sequence, when aligned using the CLUSTAL W algorithm with default parameters. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680. Default parameters for the CLUSTAL W
  • Gap extension penalty 0.05
  • Deletions are counted as non-identical residues, compared to a reference sequence. Deletions occurring at either termini are included. For example, a variant with five amino acid deletions of the C-terminus of the mature CspAmy2 polypeptide of SEQ ID NO: 1 would have a percent sequence identity of 99% (612 / 617 identical residues x 100, rounded to the nearest whole number) relative to the mature polypeptide. Such a variant would be encompassed by a variant having "at least 99% sequence identity" to a mature amylase polypeptide.
  • compositions and methods are non-naturally-occuring specialty syrups prepared from starch substrates using a-amylases. These syrups are rich in DP5 and contain reduced amounts of other oligosaccharides, such as a DP6, DP3, and DP2 compared to typical syrups. Such syrups have applications in the food and beverage industry as sweeteners. In addition, the syrups are useful for preparing purified DP5, which has been used as a nutrient for patients with renal failure and in a state of calorie-deprivation. DP5 is also used a substrate in commercially available a-amylase assays.
  • the syrups can be defined by the amount of DP5 they contain as a fraction of total reaction products (i.e. , total soluble sugars) after incubation for a given period of time (e.g. , 30 hours) with a-amylase. In some embodiments, the amount of DP5 as a fraction of total reaction products is >30%, >35%, or even >40%.
  • the syrups can be defined by the amount of DP6 they contain as a fraction of total reaction products after incubation for a given period of time (e.g. , 30 hours) with a-amylase. In some embodiments, the amount of DP6 as a fraction of total reaction products is ⁇ 10%, ⁇ 7%, or even ⁇ 5%.
  • the syrups can also be defined by the amount of DP5 they contain relative to the amount of a different
  • the DP6/DP5 is ⁇ 0.50, ⁇ 0.45, ⁇ 0.40, ⁇ 0.35, ⁇ 0.30, ⁇ 0.25, ⁇ 0.20, ⁇ 0.15, or even ⁇ 0.10.
  • DP3/DP5 is ⁇ 0.70, ⁇ 0.65, or even ⁇ 0.60.
  • DP2/DP5 is ⁇ 0.50, ⁇ 0.45, ⁇ 0.40, or even ⁇ 0.35.
  • DP1/DP5 is >0.20, or even >0.25.
  • the syrups are particularly useful as a source of DP5. However, they can also be used for the preparation of HFCS or can be converted into a number of other useful products, such as ascorbic acid intermediates (e.g. , gluconate; 2-keto-L-gulonic acid; 5-keto-gluconate; and 2,5-diketogluconate); 1,3-propanediol; aromatic amino acids (e.g. , tyrosine, phenylalanine and tryptophan); organic acids (e.g.
  • the syrups may be a precursor to, or may be prepared simultaneous with, a fermentation process designed to produce alcohol for fuel or drinking (i.e., potable alcohol).
  • the DP5-enriched syrups are produced by contacting a starch substrate with a suitable a- amylase, as exemplified by an a- amylase from a Cytophaga sp., herein refered to as CspAmy2.
  • a suitable a- amylase as exemplified by an a- amylase from a Cytophaga sp., herein refered to as CspAmy2.
  • the oligosaccharides product profile of CspAmy2 is unusual in that the enzyme produces large amounts of DP5 and small amounts of other oligosaccharides to produce the syrup described, above.
  • a-amylases such as Bacillus licheniformis a-amylase, also produces a significant amount of DP5, they do not produce syrups with, for example, such a high DP5/DP6 ratio.
  • CspAmy2 which was previously described by Jeang, C-L. et al. ((2002) Applied and Environmental Microbiology, 68:3651-54).
  • the amino acid sequence of the mature form of the CspAmy2 a-amylase polypeptide is shown below as SEQ ID NO: 1 :
  • CspAmy2 and CspAmy2-vl are expected to have the same oligosaccharide product profiles; however, CspAmy2-vl is more stable (data not shown).
  • CspAmy2 expected to have similar thermostability to CspAmy2-vl is a CspAmy2 variant in which residues T180 and G181 are deleted.
  • the amino acid sequence of the mature form of this variant of the CspAmy2 a-amylase polypeptide is shown below as SEQ ID NO: 3:
  • the present a-amylase variants have indicated combinations of mutations and a defined degree of amino acid sequence homology/identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, for example, at least 60%, at least 65%, at least 70%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% amino acid sequence
  • the present ⁇ -amylase variants have indicated combinations of mutations and are derived from a parental amylase having a defined degree of amino acid sequence homology/identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, for example, at least 60%, at least 65%, at least 70%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% amino acid sequence homology/identity.
  • the present a- amylases further include one or more mutations that provide a further performance benefit.
  • mutations that have been previously described in a-amylases having at least 60%, at least 65%, at least 70%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% amino acid sequence homology/identity to SEQ ID NO: 1.
  • embodiments of the present variant a-amylases include variants having a mutation at an amino acid position corresponding to E187 or S241, optionally in combination with at least one mutation at an amino acid position corresponding to a position selected from N126, Y150, F153, L171, T180, and 1203 (using SEQ ID NO: 1 for numbering).
  • Exemplary mutations at amino acid position E187 include E187V and E187P.
  • Exemplary mutations at amino acid position S241 include S241Q and S241A.
  • Exemplary mutations at amino acid position N126 includes N126Y.
  • Exemplary mutations at amino acid position Y150 include Y150F, Y150H, and Y150W.
  • Exemplary mutations at amino acid position F153 include F153H, F153W, and F153Y.
  • Exemplary mutations at amino acid position L171 include L171F, L171G, L171I, L171M, L171R, L171V, L171W, L171Y, L171H, L171K, L171N, L171Q, and L171S.
  • Exemplary mutations at amino acid position T180 include T180D and T180H.
  • Exemplary mutations at amino acid position 1203 includes I203C, I203V, I203F, I203L, I203M, and I203Y.
  • the variant ⁇ -amylases include a mutation in amino acid residues corresponding to E132, Q167, A277, and/or T400, using SEQ ID NO: 1 for numbering.
  • Exemplary mutations at amino acid position E132 include E132A, E132C, E132D, E132F, E132G, E132H, E132I, E132K, E132L, E132M, E132N, E132P, E132Q, E132R, E132V, and E132W.
  • Exemplary mutations at amino acid position Q167 include Q167A, Q167D, Q167E, Q167G, Q167H, Q167K, Q167M, Q167N, Q167P, Q167S, Q167T, and Q167V.
  • Exemplary mutations at amino acid position A277 include A277C, A277D, A277E, A277F, A277G, A277I, A277K, A277L, A277M, A277N, A277Q, A277R, A277S, A277T, A277V, A277W, and A277Y.
  • Exemplary mutations at amino acid position T400 include T400A, T400C, T400D, T400F, T400G, T400I, T400K, T400L, T400M, T400N, T400Q, T400R, T400W, and T400Y.
  • the variant a-amylases include a mutation in an amino acid residue corresponding to G476, using SEQ ID NO: 1 for numbering.
  • Exemplary mutations at amino acid position G476 include G476A, G476C, G476H, G476K, G476N, G476P, G476Q, G476R, G476S, G476T, G476V, and G476Y.
  • the variant a-amylases are those that include mutations in both amino acid residues corresponding to G476 and G477, using SEQ ID NO: 1 for numbering.
  • the variant ⁇ -amylases include mutations in amino acid residues corresponding to R458, T459, and/or D460.
  • Exemplary mutations are R458N, T459S, and D460T, respectively.
  • the variant ⁇ -amylases include mutations at positions corresponding to E132 and/or T180 (using SEQ ID NO: 1 for numbering), in combination with an RG-deletion or a TG-deletion (or equivalent deletion based on the sequence of the parent a-amylases), such that a stabilizing interaction can occur between the remaining non-G residue in the XiG/SiXiGi motif and the residue at position 132.
  • the residue at position 132 is negatively charged (i.e., D or E) and the remaining non-G residue is positively charged (i.e., H, R, or K).
  • the residue at position 132 is positively charged (i.e., H, R, or K) and the remaining non-G residue is negatively charged (i.e., D or E).
  • Additional mutations experimentally determined to provide at least one performance advantage when combined with the aforementioned variants include mutations at positions corresponding to 6, 7, 8, 11, 14, 15, 20, 21, 23, 26, 27, 28, 37, 38, 39, 40, 42, 45, 46, 48, 49,
  • corresponding amino acid positions in other a-amylases be identified by amino acid sequence alignment with CspAmy2 (SEQ ID NO: 1) using Clustal W with default parameters.
  • Preferred CspAmy2 variants produce at least as much DP5, in absolute or relative amounts, as the parental CspAmy2 a-amylase, and/or demonstrate a further performance benefit, as described, herein.
  • the CspAmy2 variants produce more DP5, in absolute or relative amounts, compared to the parental CspAmy2 a- amylase.
  • the present amylases may include any number of conservative amino acid
  • the present amylase may be "precursor,” “immature,” or “full-length,” in which case they include a signal sequence, or “mature,” in which case they lack a signal sequence. Mature forms of the polypeptides are generally the most useful. Unless otherwise noted, the amino acid residue numbering used herein refers to the mature forms of the respective amylase polypeptides. The present amylase polypeptides may also be truncated to remove the N or C-termini, so long as the resulting polypeptides retain amylase activity.
  • the present amylase may be a "chimeric" or “hybrid” polypeptide, in that it includes at least a portion of a first amylase polypeptide, and at least a portion of a second amylase polypeptide (such chimeric amylases have recently been “rediscovered” as domain-swap amylases).
  • the present amylases may further include heterologous signal sequence, an epitope to allow tracking or purification, or the like.
  • Exemplary heterologous signal sequences are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA.
  • a useful starch substrate may be obtained from tubers, roots, stems, legumes, cereals or whole grain. More specifically, the granular starch may be obtained from e.g., corn, cobs, wheat, barley, rye, triticale, milo, sago, millet, cassava, tapioca, sorghum, rice, peas, bean, banana, or potatoes. Corn contains about 60-68% starch; barley contains about 55-65% starch; millet contains about 75-80% starch; wheat contains about 60-65% starch; and polished rice contains 70-72% starch. Specifically contemplated starch substrates are corn starch and wheat starch.
  • the starch from a grain may be ground or whole and includes corn solids, such as kernels, bran and/or cobs.
  • the starch may also be highly refined raw starch or feedstock from starch refinery processes.
  • Various starches also are commercially available.
  • corn starch is available from Cerestar, Sigma, and Katayama Chemical Industry Co. (Japan); wheat starch is available from Sigma; sweet potato starch is available from Wako Pure Chemical Industry Co. (Japan); and potato starch is available from Nakaari Chemical Pharmaceutical Co. (Japan).
  • the starch substrate can be a crude starch from milled whole grain, which contains non-starch fractions, e.g., germ residues and fibers.
  • Milling may comprise either wet milling or dry milling or grinding.
  • wet milling whole grain is soaked in water or dilute acid to separate the grain into its component parts, e.g., starch, protein, germ, oil, kernel fibers.
  • Wet milling efficiently separates the germ and meal (i.e., starch granules and protein) and is especially suitable for production of syrups.
  • whole kernels are ground into a fine powder and often processed without fractionating the grain into its component parts. In some cases, oils from the kernels are recovered.
  • Dry ground grain thus will comprise significant amounts of non-starch carbohydrate compounds, in addition to starch.
  • Dry grinding of the starch substrate can be used for production of ethanol and other biochemicals.
  • the starch substrate can also be from a direct starch to sugar process, a raw or granular starch hydrolysis process.
  • the starch substrate can also be a hydrolyzed form of starch, such as maltodextrin.
  • the starch substrate to be processed may optionally be refined and may be, for example, at least 90%, at least 95%, at least 97%, or at least 99.5% pure.
  • Liquefaction refers to a process by which starch is converted to less viscous and shorter chain carbohydrates. Generally, this process involves gelatinization of starch simultaneously with or followed by the addition of a-amylase, although additional enzymes may optionally be added to affect liquefaction.
  • the starch substrate as described above is slurried with water.
  • the starch slurry may contain starch at a dry solid content of about 10-55%, about 20-45%, about 30-45%, about 30-40%, or about 30-35%.
  • ⁇ x- amylase may be added to the slurry, with a metering pump, for example.
  • the pH of the slurry typically is adjusted to about pH 5.5 - 6.5 and about 1 mM of calcium (about 40 ppm free calcium ions) can also be added.
  • Bacterial a- amylase remaining in the slurry following liquefaction may be deactivated via a number of methods known in the art.
  • the slurry of starch plus the a-amylase may be pumped continuously through a jet cooker, which is steam heated to about 105-110°C. Gelatinization occurs rapidly under these conditions, and the enzymatic activity, combined with the significant shear forces, begins the hydrolysis of the starch substrate. The residence time in the jet cooker is brief.
  • the partly gelatinized starch may be passed into a series of holding tubes maintained at about 105- 110°C and held for 5-8 min. to complete the gelatinization process (i.e., "primary
  • liquefaction Secondary liquefactoin is performed in holding tanks at 85-95°C or higher temperatures for about 1 to 2 hours . These tanks may contain baffles to discourage back mixing. The slurry is then allowed to cool, typically to about 60-64° or even to room temperature. Starch processing may in some cases also be conducted entirely below the gelatinizing temperature of starch.
  • the liquefied starch typically is in the form of a slurry having a dry solids content (w/w) of about 10-50%; about 10-45%; about 15-40%; about 20- 40%; about 25-40%; or about 28-38%.
  • Liquefaction with a-amylases advantageously can be conducted at low pH, eliminating the requirement to adjust the pH to about pH 5.5 - 6.5.
  • a-amylases can be used for liquefaction at a pH range of 2.0 - 7.0, e.g., pH 3.0 - 7.5, pH 4.0 - 6.0, or pH 4.5 - 5.8.
  • ⁇ x- amylases can maintain liquefying activity at a temperature range of about 85°C - 95°C, e.g., 85°C, 90°C, or 95°C.
  • secondary liquefaction can be conducted with a solution of 25% DS corn starch for 10 min at pH 5.8 and 85°C, or pH 4.5 and 95°C.
  • Liquefying activity can be assayed using any of a number of known assays in the art.
  • Saccharification refers to a process by which a starch substrate produced in liquefaction, also called liquefact, or a starch substrate generated through granular starch hydrolysis, is further hydrolysed into a specialty syrup or into glucose.
  • Enzymes used for saccharification include a- amylases, ⁇ -amylases, glucoamylases, pullulanases, and maltogenic amylases, depending on the desired end product.
  • the pH may vary between 4.0 - 6.0 and the temperature between 55 - 70°C, for example, 58 - 64°.
  • the process is typically carried out for at least 6, at least 12, at least 24, at least 36, at least 48, at least 60, at least 72, at least 84, or even at least 96 hours.
  • the properties of the enzymes are also important. Particularly where it is desirable for the end product to be a specialty syrup containing a large amount of particular oligosaccharides, such as DP5 (as opposed to mainly glucose), the enzymatic properties of the a-amylase have a significant effect on the final syrup.
  • the commercially available products were dosed at 0.2 kg/MT DS.
  • CspAmy2-vl was dosed at 0.006 mg/g DS.
  • the target amount of enzyme in the corn starch liquefact was typically about 0.006 mg/g DS. Since the size distribution of starch hydrolysis products is primarily a feature of the ⁇ -amylase rather than the concentration of the a-amylase, minor differences in the final concentration of ⁇ -amylase were not considered to be important.
  • the concentrations of each ⁇ -amylase used are shown in Table 2. Table 2.

Abstract

Disclosed are compositions and methods relating to DP5-enriched specialty syrups prepared from starch substrates using α-amylases. The syrups have application in the food and beverage industry.

Description

DP5 -ENRICHED SYRUPS
CROSS REFERENCE TO RELATED APPLICATIONS
[001] This application claims benefit of priority from US provisional application USSN 62/044,583, filed September 2, 2014, which is herein incorporated by reference in its entirety.
FIELD OF THE INVENTION
[002] Disclosed are compositions and methods relating to DP5-enriched specialty syrups prepared from starch substrates using a-amylases. The syrups have applications in the food and beverage industry.
BACKGROUND
[003] Starch consists of a mixture of amylose (15-30% w/w) and amylopectin (70-85% w/w). Amylose consists of linear chains of a-l,4-linked glucose units having a molecular weight (MW) from about 60,000 to about 800,000. Amylopectin is a branched polymer containing a- 1,6 branch points every 24-30 glucose units; its MW may be as high as 100 million.
[004] Sugars from starch, usually in the form of concentrated dextrose (glucose) syrups, are currently produced by an enzyme catalyzed process involving: (1) liquefaction (dissolving and hydrolysis of starch with an a-amylase into dextrins having an average degree of polymerization of about 7-10, and (2) saccharification of the resulting liquefied starch (i.e. starch hydrolysate) with amyloglucosidase (also called glucoamylase or GA). The resulting syrup has a high dextrose content. Much of the glucose syrup that is commercially produced is subsequently enzymatically isomerized to a dextrose/fructose mixture known as isosyrup. The resulting syrup may be fermented with microorganisms, such as yeast, to produce commercial products including ethanol, citric acid, lactic acid, succinic acid, itaconic acid, monosodium glutamate, gluconates, lysine, other organic acids, other amino acids, and other biochemicals, for example. Fermentation and saccharification can be conducted
simultaneously (i.e., an SSF process) to achieve greater economy and efficiency. In some cases, the syrup produced following incubation with a-amylases is itself a valuable product, and it is not desirable to fully process the syrup to glucose or to otherwise enzymatically process or ferment the syrup. [005] α-amylases are endo-acting enzymes and have a minimum starch substrate length requirement. As a result, a-amylases tend to produce a population of oligosaccharides of varying length and little glucose. These oligosaccharides are identified by the number of glucose residues they contain, also referred to as their degree of polymerization (DP).
Different α-amylases produce a different population of products. Some oligosaccharides are more desirable than others. For example, oligosaccharides containing five glucose residues (i.e., G5 or DP5) have been used as a nutrients for patients with renal failure and those in a state of calorie-deprivation. DP5 is also used a substrate in commercially available a- amylase assays.
[006] While α-amylases that produce DP5 as a significant proportion of total
oligosaccharides products have been described (e.g., Okemoto, H. et al. (1986) Appl.
Microbiol. Biotechnol. 25: 137-42; Saito, N. (1973) Arch. Biochem. Biophys. 155:290-98; Morgan, F. J. and Priest, F.G. (1981) /. Appl. Bacteriol. 50: 107-14; Shida, O. et al. (1992) Biosci. Biotech. Biochem. 56:76-80), the need exists for amylases that can produce even higher amounts of DP5, preferably with reduced amounts of similar sized products, such as DP6.
SUMMARY
[007] The present compositions and methods relate to DP5-enriched specialty syrups and a- amylases used to produce them. Aspects and embodiments of the compositions and methods are illustrated by the following separately- numbered paragraphs:
1. In one aspect, a non-naturally-occurring syrup produced from a starch substrate by incubation with an α-amylase is provided, comprising >30 DP5 and <10 DP6 as fractions of total reaction products or DP6/DP5 <0.30, DP3/DP5 <0.70, and DP2/DP5 <0.50.
2. In some embodiments, the syrup of paragraph 1 has DP6/DP5 <0.30.
3. In some embodiments, the syrup of paragraph 1 has DP6/DP5 <0.20.
4. In some embodiments, the syrup of paragraph 1 has DP6/DP5 <0.15.
5. In some embodiments, the syrup of any of paragraphs 1-4 is produced by incubating a starch substrate in the presence of CspAmy2 α-amylase or a variant, thereof.
6. In some embodiments, the syrup of paragraph 5 is produced by an a-amylase variant of CspAmy2 comprising a deletion of residues 178 and 179 or 180 and 181, using SEQ ID NO: 3 for numbering.
7. In another aspect, a method for producing a syrup from a starch substrate is provided, comprising incubating the starch substrate in the presence of an α-amylase capable of producing >30% DP5 and <10% DP6 as fractions of total reaction products, or DP6/DP5 <0.30, DP3/DP5 <0.70, and DP2/DP5 <0.50, in a period of 30 hours at pH 5.2 and 60°C.
8. In some embodiments of the method of paragraph 7, the a-amylase is capable of producing a reaction product having a DP6/DP5 <0.30 in a period of 30 hours at pH 5.2 and 60°C.
9. In some embodiments of the method of paragraph 8, the α-amylase is capable of producing a reaction product having a DP6/DP5 <0.20 in a period of 30 hours at pH 5.2 and 60°C.
10. In some embodiments of the method of paragraph 9, the α-amylase is capable of producing a reaction product having a DP6/DP5 <0.15 in a period of 30 hours at pH 5.2 and 60°C.
11. In some embodiments of the method of any of paragraphs 7-10, the starch substrate is a corn, cereal, grain, or tuber liquefact.
12. In some embodiments of the method of any of paragraphs 7-11, the starch substrate comprises from about 10% to about 40% dissolved solids.
13. In some embodiments of the method of any of paragraphs 7-12, the amount of a- amylase used is from about 0.001 to about 0.05 mg/g dissolved solids.
14. In some embodiments of the method of any of paragraphs 7-12, incubating the starch substrate in the presence of α-amylase is performed without the addition of calcium to the starch substrate.
15. In some embodiments of the method of any of paragraphs 7-13, incubating the starch substrate in the presence of CspAmy2 α-amylase or a variant, thereof, is performed at a pH <7.0.
16. In some embodiments of the method of any of paragraphs 7-14, incubating the starch substrate in the presence of α-amylase is performed at a pH <6.0.
17. In some embodiments of the method of any of paragraphs 7-15, the starch substrate is incubated in the presence of CspAmy2 α-amylase or a variant, thereof.
18. In some embodiments of the method of paragraph 17, the α-amylase is a variant of CspAmy2 comprising a deletion of residues 178 and 179 or 180 and 181, using SEQ ID NO: 3 for numbering.
19. In another aspect, a syrup produced by the method of any of paragraphs 7-18 is provided.
[008] These and other aspects and embodiments of the compositions and methods will be apparent from the present description and drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[009] Figure 1 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with CspAmy2.
[0010] Figure 2 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with SPEZYME XTRA®.
[0011] Figure 3 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with SPEZYME ALPHA®.
[0012] Figure 4 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with SPEZYME FRED®.
[0013] Figure 5 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with OPTEVIASE® AA 56L.
[0014] Figure 6 is a graph showing the relative amounts of oligosaccharides produced over time following incubation of a starch substrate with PURASTAR® HP Am 5000L.
[0015] Figure 7 is a graph showing the relative amounts of DP5 produced over time following incubation of a starch substrate with CspAmy2, OPTEVIASE® AA 56L, or
PURASTAR® HP Am 5000L.
[0016] Figure 8 is a graph showing the relative amounts of DP5, DP6, DP3 and DP2 produced over time following incubation with different amounts of CspAmy2.
DETAILED DESCRIPTION
1. Definitions and Abbreviations
[0017] In accordance with this detailed description, the following abbreviations and definitions apply. Note that the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "an enzyme" includes a plurality of such enzymes, and reference to "the dosage" includes reference to one or more dosages and equivalents thereof known to those skilled in the art, and so forth.
[0018] The present document is organized into a number of sections for ease of reading; however, the reader will appreciate that statements made in one section may apply to other sections. In this manner, the headings used for different sections of the disclosure should not be construed as limiting.
[0019] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. Selected abbreviations and terms are defined, below. 1.1. Abbreviations and Acronyms
[0020] The following abbreviations/acronyms have the following meanings unless otherwise specified:
DE dextrose equivalent
DPn degree of saccharide polymerization having n subunits ds or DS dry solids
EC Enzyme Commission
HFCS high fructose corn syrup
MT metric ton
kg/MT DS kilograms per metric ton dry solid
MW molecular weight
ppm parts per million, e.g., μg protein per gram dry solid
SSF simultaneous saccharification and fermentation
sp. species
w/v weight/volume
w/w weight/weight
v/v volume/volume
wt weight percent
°C degrees Centigrade
RI refractive index
H20 water
dH20 or DI deionized water
dIH20 deionized water, Milli-Q filtration
g or gm grams
μg micrograms
mg milligrams
mg/g DS milligrams per gram of dry solid
kg kilograms
μL· and μΐ microliters
mL and ml milliliters
mm millimeters
μιη micrometer
M molar
mM millimolar
μΜ micromolar
U units
sec seconds
min(s) minute/minutes
hr(s) hour/hours
eq. equivalents
N normal
> greater than
< less than
> greather than or equal to
< less than or equal to 1.2. Definitions
[0021] The terms "amylase" or "amylolytic enzyme" refer to an enzyme that is, among other things, capable of catalyzing the degradation of starch, a-amylases are hydrolases that cleave the a-D-(l→4) O-glycosidic linkages in starch. Generally, a-amylases (EC 3.2.1.1; a-D- (l→4)-glucan glucanohydrolase) are defined as endo-acting enzymes cleaving a-D-(l→4) O- glycosidic linkages within the starch molecule in a random fashion yielding polysaccharides containing three or more (l-4)-a-linked D-glucose units. In contrast, the exo-acting amylolytic enzymes, such as β-amylases (EC 3.2.1.2; a-D-(l→4)-glucan maltohydrolase) and some product- specific amylases like maltogenic a-amylase (EC 3.2.1.133) cleave the polysaccharide molecule from the non-reducing end of the substrate, β-amylases, a- glucosidases (EC 3.2.1.20; a-D-glucoside glucohydrolase), glucoamylase (EC 3.2.1.3; a-D- (l→4)-glucan glucohydrolase), and product- specific amylases like the maltotetraosidases (EC 3.2.1.60) and the maltohexaosidases (EC 3.2.1.98) can produce malto-oligosaccharides of a specific length or enriched syrups of specific maltooligosaccharides.
[0022] The term "starch" refers to any material comprised of the complex polysaccharide carbohydrates of plants, comprised of amylose and amylopectin. The term includes plant- based materials such as grains, cereal, grasses, tubers and roots, and more specifically materials obtained from wheat, barley, corn, rye, rice, sorghum, brans, cassava, millet, milo, potato, sweet potato, and tapioca. The term "starch" includes granular starch.
[0023] The term "granular starch" refers to raw, i.e., uncooked starch, e.g., starch that has not been subject to gelatinization.
[0024] The term "monosaccharide" refers to a carbohydrate that cannot be hydrolyzed to produce more simple sugars. Monosaccharides are also referred to as monosaccharide units, glucopyranose units, monomers, and residues.
[0025] The term "oligosaccharide" refers to a carbohydrate consisting of two to ten monosaccharide units.
[0026] The term "polysaccharide" refers to a carbohydrate consisting of more than 10 linked monosaccharide units.
[0027] A "syrup" is a liquid containing dissolved monosaccharides, oligosaccharides, and soluble polysaccharides.
[0028] The term "total soluble sugars" refers to all dissolved monosaccharides,
oligosaccharides, and soluble polysaccharides in a syrup. Where the syrup is produced by incubating a starch substrate with an a-amylase, total soluble sugars is synonymous with the term "total reaction products."
[0029] A "non-naturally-occurring syrup" is a liquid containing dissolved monosaccharides, oligosaccharides, and soluble polysaccharides that is produced by the intentional addition of a-amylase to a starch composition. Non-naturally-occurring syrups exclude syrups that occur in nature and do not involve the hand of man.
[0030] A "specialty syrup" is a syrup containing a specified relative amount of dissolved monosaccharide, oligosaccharide, and soluble polysaccharide components, for example, >30 DP5 relative to total soluble sugars, <10 DP6 relative to total soluble sugars, or a specified ratio of DP5 to DP6, DP5 to DP3, and the like.
[0031] The term "degree of polymerization" (DP) refers to the number (n) of glucopyranose units in a given saccharide. Examples of DPI are the monosaccharides glucose and fructose. Examples of DP2 are disaccharides such as maltose and sucrose.
[0032] The term DP>10 refers to all soluble saccharides longer than DP 10 that can be measured by HPLC using the column and assay method specified in the Examples.
[0033] The term "DE," or "dextrose equivalent," is defined as the percentage of reducing sugar, i.e., D-glucose, as a fraction of total carbohydrate in a syrup.
[0034] The term "dry solids content" (ds) refers to the total solids of a slurry in a dry weight percent basis.
[0035] The term "slurry" refers to an aqueous mixture containing insoluble solids.
[0036] The term "minutes of secondary liquefaction" refers to the elapsed time of from the start of secondary liquefaction.
[0037] The terms, "wild-type," "parental," or "reference," with respect to a polypeptide, refer to a naturally-occurring polypeptide that does not include a man-made substitution, insertion, or deletion at one or more amino acid positions. Reference to the wild-type polypeptide is understood to include the mature form of the polypeptide.
[0038] A "mature" polypeptide or variant, thereof, is one in which a signal sequence is absent, for example, cleaved from an immature form of the polypeptide during or following expression of the polypeptide.
[0039] The term "variant," with respect to a polypeptide, refers to a polypeptide that differs from a specified wild-type, parental, or reference polypeptide in that it includes one or more naturally-occurring or man-made substitutions, insertions, or deletions of an amino acid. The identity of the wild-type, parental, or reference polypeptide or polynucleotide will be apparent from context. [0040] The term "specific activity" refers to the number of moles of substrate that can be converted to product by an enzyme or enzyme preparation per unit time under specific conditions. Specific activity is generally expressed as units (U)/mg of protein.
[0041] The term "performance benefit" refers to an improvement in a desirable property of a molecule. Exemplary performance benefits include, but are not limited to, increased hydrolysis of a starch substrate, increased grain, cereal or other starch substrate liquefaction, improved oligosaccharide reaction product profile, improved viscosity reduction, increased thermal stability, increased storage stability, increased solubility, an altered pH profile, decreased calcium dependence, increased specific activity, modified substrate specificity, modified substrate binding, modified pH-dependent activity, modified pH-dependent stability, increased oxidative stability, and increased expression. In some cases, the performance benefit is realized at a relatively low temperature. In some cases, the performance benefit is realized at relatively high temperature.
[0042] The term "recombinant," when used in reference to a subject cell, nucleic acid, protein or vector, indicates that the subject has been modified from its native state. Thus, for example, recombinant cells express genes that are not found within the native (non- recombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature. Recombinant nucleic acids differ from a native sequence by one or more nucleotides and/or are operably linked to heterologous sequences, e.g., a heterologous promoter in an expression vector. Recombinant proteins may differ from a native sequence by one or more amino acids and/or are fused with heterologous sequences. A vector comprising a non-native gene encoding an amylase is a recombinant vector.
[0043] The terms "recovered," "isolated," and "separated," refer to a compound, protein (polypeptide), cell, nucleic acid, amino acid, or other specified material or component that is removed from at least one other material or component with which it is naturally associated as found in nature.
[0044] The term "purified" refers to material (e.g. , an isolated polypeptide, DP5, etc.) that is in a relatively pure state, e.g. , at least about 90% pure, at least about 95% pure, at least about 98% pure, or even at least about 99% pure.
[0045] The terms "thermostable" and "thermostability," with reference to an enzyme, refer to the ability of the enzyme to retain activity after exposure to an elevated temperature. The thermostability of an enzyme, such as an amylase enzyme, is measured by its half-life (tl/2) given in minutes, hours, or days, during which half the enzyme activity is lost under defined conditions. The half-life may be calculated by measuring residual a- amylase activity following exposure to (i.e. , challenge by) an elevated temperature.
[0046] The term "amino acid sequence" is synonymous with the terms "polypeptide,"
"protein," and "peptide," and are used interchangeably. Where such amino acid sequences exhibit activity, they may be referred to as an "enzyme." The conventional one-letter or three-letter codes for amino acid residues are used, with amino acid sequences being presented in the standard amino-to-carboxy terminal orientation (i.e. , N→C).
[0047] The term "expression" refers to the process by which a polypeptide is produced based on a nucleic acid sequence. The process includes both transcription and translation.
[0048] As used herein, "water hardness" is a measure of the minerals (e.g. , calcium and magnesium) present in water.
[0049] "A cultured cell material comprising an amylase" or similar language, refers to a cell lysate or supernatant (including media) that includes an amylase as a component. The cell material may be from a heterologous host that is grown in culture for the purpose of producing the amylase.
[0050] "Percent sequence identity" means that a particular sequence has at least a certain percentage of amino acid residues identical to those in a specified reference sequence, when aligned using the CLUSTAL W algorithm with default parameters. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680. Default parameters for the CLUSTAL W
Gap opening penalty: 10.0
Gap extension penalty: 0.05
Protein weight matrix: BLOSUM series
DNA weight matrix: IUB
Delay divergent sequences %: 40
Gap separation distance: 8
DNA transitions weight: 0.50
List hydrophilic residues: GPSNDQEKR
Use negative matrix: OFF
Toggle Residue specific penalties: ON
Toggle hydrophilic penalties: ON
Toggle end gap separation penalty OFF.
[0051] Deletions are counted as non-identical residues, compared to a reference sequence. Deletions occurring at either termini are included. For example, a variant with five amino acid deletions of the C-terminus of the mature CspAmy2 polypeptide of SEQ ID NO: 1 would have a percent sequence identity of 99% (612 / 617 identical residues x 100, rounded to the nearest whole number) relative to the mature polypeptide. Such a variant would be encompassed by a variant having "at least 99% sequence identity" to a mature amylase polypeptide.
[0052] The term "about" refers to + 15% to the referenced value.
2. DP5-enriched syrups
[0053] An aspect of the present compositions and methods are non-naturally-occuring specialty syrups prepared from starch substrates using a-amylases. These syrups are rich in DP5 and contain reduced amounts of other oligosaccharides, such as a DP6, DP3, and DP2 compared to typical syrups. Such syrups have applications in the food and beverage industry as sweeteners. In addition, the syrups are useful for preparing purified DP5, which has been used as a nutrient for patients with renal failure and in a state of calorie-deprivation. DP5 is also used a substrate in commercially available a-amylase assays.
[0054] The syrups can be defined by the amount of DP5 they contain as a fraction of total reaction products (i.e. , total soluble sugars) after incubation for a given period of time (e.g. , 30 hours) with a-amylase. In some embodiments, the amount of DP5 as a fraction of total reaction products is >30%, >35%, or even >40%. The syrups can be defined by the amount of DP6 they contain as a fraction of total reaction products after incubation for a given period of time (e.g. , 30 hours) with a-amylase. In some embodiments, the amount of DP6 as a fraction of total reaction products is <10%, <7%, or even <5%. The syrups can also be defined by the amount of DP5 they contain relative to the amount of a different
oligosaccharide, such as DP6, DP3, DP2, or DPI, after incubation for a given period of time (e.g. , 30 hours) with a-amylase. In some embodiments, the DP6/DP5 is <0.50, <0.45, <0.40, <0.35, <0.30, <0.25, <0.20, <0.15, or even <0.10. In some embodiments, DP3/DP5 is <0.70, <0.65, or even <0.60. In some embodiments, DP2/DP5 is <0.50, <0.45, <0.40, or even <0.35. In some embodiments, DP1/DP5 is >0.20, or even >0.25.
[0055] The syrups are particularly useful as a source of DP5. However, they can also be used for the preparation of HFCS or can be converted into a number of other useful products, such as ascorbic acid intermediates (e.g. , gluconate; 2-keto-L-gulonic acid; 5-keto-gluconate; and 2,5-diketogluconate); 1,3-propanediol; aromatic amino acids (e.g. , tyrosine, phenylalanine and tryptophan); organic acids (e.g. , lactate, pyruvate, succinate, isocitrate, and oxaloacetate); amino acids (e.g., serine and glycine); antibiotics; antimicrobials; enzymes; vitamins; and hormones. [0056] Alternatively, the syrups may be a precursor to, or may be prepared simultaneous with, a fermentation process designed to produce alcohol for fuel or drinking (i.e., potable alcohol).
3. a-Amylases for producing DP5-enriched syrups
[0057] The DP5-enriched syrups are produced by contacting a starch substrate with a suitable a- amylase, as exemplified by an a- amylase from a Cytophaga sp., herein refered to as CspAmy2. The oligosaccharides product profile of CspAmy2 is unusual in that the enzyme produces large amounts of DP5 and small amounts of other oligosaccharides to produce the syrup described, above. While other a-amylases, such as Bacillus licheniformis a-amylase, also produces a significant amount of DP5, they do not produce syrups with, for example, such a high DP5/DP6 ratio.
[0058] CspAmy2, which was previously described by Jeang, C-L. et al. ((2002) Applied and Environmental Microbiology, 68:3651-54). The amino acid sequence of the mature form of the CspAmy2 a-amylase polypeptide is shown below as SEQ ID NO: 1 :
AATNGTMMQY FEWYVPNDGQ QWNRLRTDAP YLSSVGITAV WTPPAYKGTS
QADVGYGPYD LYDLGEFNQK GTVRTKYGTK GELKSAVNTL HSNGIQVYGD
VVMNHKAGAD YTENVTAVEV NPSNRNQETS GEYNIQAWTG FNFPGRGTTY
SNFKWQWFHF DGTDWDQSRS LSRIFKFRGT GKAWDWEVSS ENGNYDYLMY
ADIDYDHPDV VNEMKKWGVW YANEVGLDGY RLDAVKHIKF SFLKDWVDNA
RAATGKEMFT VGEYWQNDLG ALNNYLAKVN YNQSLFDAPL HYNFYAASTG
GGYYDMR IL NNTLVASNPT KAVTLVENHD TQPGQSLEST VQPWFKPLAY
AFILTRSGGY PSVFYGDMYG TKGTTTREIP ALKSKIEPLL KARKDYAYGT
QRDYIDNPDV IGWTREGDST KAKSGLATVI TDGPGGSKRM YVGTSNAGEI
WYDLTGNRTD KITIGSDGYA TFPVNGGSVS VWVQQ
[0059] In SEQ ID NO: 1, R178 and G179 are underlined. A variant of the Cytophaga sp. a- amylase having a deletion of both R178 and G179 (herein, "CspAmy2-vl") has also been described (Shiau, R-J. et al. (2003) Applied and Environmental Microbiology , 69:2383-85). The amino acid sequence of the mature CspAmy2-vl a-amylase polypeptide is shown below as SEQ ID NO: 2:
AATNGTMMQY FEWYVPNDGQ QWNRLRTDAP YLSSVGITAV WTPPAYKGTS QADVGYGPYD LYDLGEFNQK GTVRTKYGTK GELKSAVNTL HSNGIQVYGD VVMNHKAGAD YTENVTAVEV NPSNRNQETS GEYNIQAWTG FNFPGRGTTY SNFKWQWFHF DGTDWDQSRS LSRIFKFTGK AWDWEVSSEN GNYDYLMYAD IDYDHPDVVN EMKKWGVWYA NEVGLDGYRL DAVKHIKFSF LKDWVDNARA ATGKEMFTVG EYWQNDLGAL NNYLAKVNYN QSLFDAPLHY NFYAASTGGG YYDMRNILNN TLVASNPTKA VTLVENHDTQ PGQSLESTVQ PWFKPLAYAF ILTRSGGYPS VFYGDMYGTK GTTTREIPAL KSKIEPLLKA RKDYAYGTQR DYIDNPDVIG WTREGDSTKA KSGLATVITD GPGGSKRMYV GTSNAGEIWY DLTGNRTDKI TIGSDGYATF PVNGGSVSVW VQQ
[0060] CspAmy2 and CspAmy2-vl are expected to have the same oligosaccharide product profiles; however, CspAmy2-vl is more stable (data not shown). Another variant of
CspAmy2 expected to have similar thermostability to CspAmy2-vl is a CspAmy2 variant in which residues T180 and G181 are deleted. The amino acid sequence of the mature form of this variant of the CspAmy2 a-amylase polypeptide is shown below as SEQ ID NO: 3:
AATNGTMMQY FEWYVPNDGQ QWNRLRTDAP YLSSVGITAV WTPPAYKGTS QADVGYGPYD LYDLGEFNQK GTVRTKYGTK GELKSAVNTL HSNGIQVYGD VVMNHKAGAD YTENVTAVEV NPSNRNQETS GEYNIQAWTG FNFPGRGTTY SNFKWQWFHF DGTDWDQSRS LSRIFKFRGK AWDWEVSSEN GNYDYLMYAD IDYDHPDVVN EMKKWGVWYA NEVGLDGYRL DAVKHIKFSF LKDWVDNARA ATGKEMFTVG EYWQNDLGAL NNYLAKVNYN QSLFDAPLHY NFYAASTGGG YYDMRNILNN TLVASNPTKA VTLVENHDTQ PGQSLESTVQ PWFKPLAYAF ILTRSGGYPS VFYGDMYGTK GTTTREIPAL KSKIEPLLKA RKDYAYGTQR DYIDNPDVIG WTREGDSTKA KSGLATVITD GPGGSKRMYV GTSNAGEIWY DLTGNRTDKI TIGSDGYATF PVNGGSVSVW VQQ
[0061] All three of the above polypeptides, as well as additional CspAmy2 variants, are useful for practicing the present compositions and methods.
[0062] In some embodiments, the present a-amylase variants have indicated combinations of mutations and a defined degree of amino acid sequence homology/identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, for example, at least 60%, at least 65%, at least 70%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% amino acid sequence
homology/identity.
[0063] In some embodiments, the present α-amylase variants have indicated combinations of mutations and are derived from a parental amylase having a defined degree of amino acid sequence homology/identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, for example, at least 60%, at least 65%, at least 70%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% amino acid sequence homology/identity.
[0064] In some embodiments, in addition to the mutations described above, the present a- amylases further include one or more mutations that provide a further performance benefit. These include mutation that have been previously described in a-amylases having at least 60%, at least 65%, at least 70%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% amino acid sequence homology/identity to SEQ ID NO: 1.
[0065] Based on experimental data described elsewhere, embodiments of the present variant a-amylases include variants having a mutation at an amino acid position corresponding to E187 or S241, optionally in combination with at least one mutation at an amino acid position corresponding to a position selected from N126, Y150, F153, L171, T180, and 1203 (using SEQ ID NO: 1 for numbering).
[0066] Exemplary mutations at amino acid position E187 include E187V and E187P.
Exemplary mutations at amino acid position S241 include S241Q and S241A. Exemplary mutations at amino acid position N126 includes N126Y. Exemplary mutations at amino acid position Y150 include Y150F, Y150H, and Y150W. Exemplary mutations at amino acid position F153 include F153H, F153W, and F153Y. Exemplary mutations at amino acid position L171 include L171F, L171G, L171I, L171M, L171R, L171V, L171W, L171Y, L171H, L171K, L171N, L171Q, and L171S. Exemplary mutations at amino acid position T180 include T180D and T180H. Exemplary mutations at amino acid position 1203 includes I203C, I203V, I203F, I203L, I203M, and I203Y.
[0067] In some embodiments, the variant α-amylases include a mutation in amino acid residues corresponding to E132, Q167, A277, and/or T400, using SEQ ID NO: 1 for numbering. Exemplary mutations at amino acid position E132 include E132A, E132C, E132D, E132F, E132G, E132H, E132I, E132K, E132L, E132M, E132N, E132P, E132Q, E132R, E132V, and E132W. Exemplary mutations at amino acid position Q167 include Q167A, Q167D, Q167E, Q167G, Q167H, Q167K, Q167M, Q167N, Q167P, Q167S, Q167T, and Q167V. Exemplary mutations at amino acid position A277 include A277C, A277D, A277E, A277F, A277G, A277I, A277K, A277L, A277M, A277N, A277Q, A277R, A277S, A277T, A277V, A277W, and A277Y. Exemplary mutations at amino acid position T400 include T400A, T400C, T400D, T400F, T400G, T400I, T400K, T400L, T400M, T400N, T400Q, T400R, T400W, and T400Y.
[0068] In some embodiments, the variant a-amylases include a mutation in an amino acid residue corresponding to G476, using SEQ ID NO: 1 for numbering. Exemplary mutations at amino acid position G476 include G476A, G476C, G476H, G476K, G476N, G476P, G476Q, G476R, G476S, G476T, G476V, and G476Y.
[0069] In some embodiments, the variant a-amylases are those that include mutations in both amino acid residues corresponding to G476 and G477, using SEQ ID NO: 1 for numbering.
[0070] In some embodiments, the variant α-amylases include mutations in amino acid residues corresponding to R458, T459, and/or D460. Exemplary mutations are R458N, T459S, and D460T, respectively.
[0071] In some embodiments, the variant α-amylases include mutations at positions corresponding to E132 and/or T180 (using SEQ ID NO: 1 for numbering), in combination with an RG-deletion or a TG-deletion (or equivalent deletion based on the sequence of the parent a-amylases), such that a stabilizing interaction can occur between the remaining non-G residue in the XiG/SiXiGi motif and the residue at position 132. In some embodiments, the residue at position 132 is negatively charged (i.e., D or E) and the remaining non-G residue is positively charged (i.e., H, R, or K). In some embodiments, the residue at position 132 is positively charged (i.e., H, R, or K) and the remaining non-G residue is negatively charged (i.e., D or E).
[0072] Exemplary combinations of mutation (using SEQ ID NO: 1 for numbering) are shown, below:
E187P + I203Y + G476K;
E187P + 1203 Y + G476K + R458N + T459S + D460T;
T180D + E187P + I203Y + G476K;
N126Y + T180D + E187P + I203Y + G476K;
N126Y + T180D + E187P + I203Y + Y303D + G476T + G477E;
N126Y + T180D + E187P + I203Y + Y303D + N475E + G477Q;
N126Y + T180D + E187P + I203Y + Y303R + N475E + G476T + G477R;
T038N + N88H + N126Y + T129I + N134M + F153W + L171R + T180D + E187P + I203Y
+ G476K + G477E;
N126Y + E132H + T180D + E187P + I203Y + Y303D + G476T + G477E; N126Y + E187P + I203Y;
N126Y + I203Y + S241Q;
N126Y + T180H + E187P + I203Y;
N126Y + T180H + I203Y + S241Q;
N126Y + F153W + T180H + E187P + I203Y;
N126Y + F153W + T180H + I203Y + S241Q;
N126Y +Y150H + F153W + L171N + E187P + I203Y;
N126Y +Y150H + F153W + L171N + I203Y + S241Q;
N126Y +Y150H + F153W + L171N + T180H + E187P + I203Y;
N126Y +Y150H + F153W + L171N + T180H + I203Y + S241Q;
N126Y + F153W + T180D + I203Y + S241Q;
N126Y + E132H + F153W + T180D + I203Y + S241Q + A277F;
N126Y + E132H + F153W + Q167E + T180D + I203Y + S241Q + A277F; and
N126Y + E132H + F153W + Q167E + T180D + I203Y + S241Q + A277F + T400K.
[0073] All the above combinations of mutation are contemplated for use in conjunction with the aforementioned deletions at positions corresponding to R178, G179, T180, and/or G181.
Additional mutations experimentally determined to provide at least one performance advantage when combined with the aforementioned variants include mutations at positions corresponding to 6, 7, 8, 11, 14, 15, 20, 21, 23, 26, 27, 28, 37, 38, 39, 40, 42, 45, 46, 48, 49,
50, 51, 52, 53, 54, 58, 61, 62, 68, 70, 71, 72, 73, 79, 80, 81, 82, 84, 85, 87, 88, 89, 92, 93, 94,
95, 96, 97, 98, 101, 108, 111, 112, 113, 114, 115, 116, 117, 118, 120, 122, 123, 124, 126,
127, 129, 130, 131, 132, 133, 134, 136, 137, 138, 140, 142, 143, 144, 147, 148, 149, 150,
151, 152, 153, 154, 155, 156, 158, 159, 165, 167, 168, 170, 171, 172, 175, 176, 177, 180,
181, 182, 187, 190, 191, 193, 199, 200, 201, 203, 206, 208, 210, 211, 212, 214, 215, 216,
219, 221, 223, 225, 226, 227, 235, 238, 239, 240, 241, 242, 243, 245, 246, 247, 248, 249,
250, 252, 253, 254, 256, 257, 258, 260, 261, 262, 266, 267, 268, 269, 270, 271, 273, 276,
277, 279, 280, 282, 284, 285, 286, 288, 296, 299, 300, 301, 302, 303, 304, 307, 308, 310,
311, 312, 313, 316, 317, 318, 320, 321, 325, 327, 335, 338, 342, 348, 349, 352, 356, 357,
360, 362, 363, 368, 369, 377, 381, 382, 383, 384, 385, 388, 390, 392, 394, 395, 396, 397,
398, 400, 401, 402, 403, 404, 405, 407, 408, 410, 414, 415, 416, 418, 419, 420, 421, 422,
423, 424, 426, 428, 429, 430, 431, 434, 435, 436, 439, 441, 442, 444, 445, 446, 447, 448,
449, 450, 451, 454, 455, 457, 460, 461, 462, 463, 464, 465, 466, 467, 469, 470, 471, 473,
474, 475, 476, 477, 479, 480, 481, 482, 483, and 484, using SEQ ID NO: 1 for numbering.
Specific mutations are T6A, T6D, T6E, T6G, T6K, T6M, T6N, T6Q, T6S, M7A, M7V, M8C, M8F, M8I, M8L, M8Y, F11V, Y14A, Y14I, Y14Q, Y14T, Y14V, V15C, V15D, V15I, V15N, V15T, Q20A, Q20C, Q20D, Q20H, Q20K, Q20M, Q20N, Q20R, Q20S, Q20Y, Q21F, Q21W, N23A, N23C, N23D, N23E, N23H, N23K, N23Q, N23R, N23S, N23T, N23V, R26C, R26E, R26G, R26K, R26M, R26S, R26T, T27A, T27C, T27D, T27E, T27F, T27H, T27I, T27K, T27L, T27M, T27N, T27Q, T27R, T27S, T27V, T27Y, D28A, D28C, D28T, I37F, I37V, T38D, T38N, A39L, V40A, V40C, V40D, V40G, V40H, V40I, V40K, V40M, V40P, V40Q, V40R, V40S, V40T, V40W, V40Y, T42A, T42C, T42I, T42M, T42V, A45C, A45G, Y46F, G48A, T49I, S50A, S50C, S50E, S50G, S50K, S50M, S50N, S50Q, S50R, S50T, S50Y, Q51C, Q51D, Q51E, Q51S, Q51V, A52C, A52D, A52E, A52F, A52G, A52H, A52K, A52L, A52M, A52R, A52S, A52T, A52V, A52Y, D53E, V54N, V54T, P58A, P58C, P58H, P58I, P58S, P58T, P58V, L61M, L61V, Y62A, Y62C, Y62D, Y62F, Y62G, Y62H, Y62I, Y62K, Y62L, Y62M, Y62N, Y62P, Y62Q, Y62R, Y62S, Y62V, N68C, N68D, N68E, N68F, N68H, N68L, N68P, N68Q, N68R, N68S, N68V, N68W, N68Y, K70R, G71A, G71C, G71D, G71E, G71K, G71R, G71S, T72G, T72S, V73S, T79F, T79I, T79L, T79M, T79N, T79S, T79Y, K80A, K80C, K80D, K80F, K80H, K80I, K80M, K80N, K80Q, K80R, K80S, K80T, K80V, K80Y, G81A, G81D, G81E, G81F, G81H, G81I, G81K, G81N, G81P, G81R, G81S, G81T, E82A, E82D, E82M, E82Q, K84A, K84C, K84E, K84I, K84Q, K84R, K84S, K84T, K84Y, S85A, S85C, S85D, S85E, S85G, S85H, S85I, S85L, S85M, S85N, S85Q, S85R, S85T, S85V, S85Y, V87I, V87T, N88C, N88D, N88E, N88G, N88H, N88I, N88K, N88L, N88M, N88Q, N88R, N88S, N88T, N88V, N88W, N88Y, T89A, T89D, T89E, T89F, T89H, T89I, T89K, T89L, T89M, T89N, T89Q, T89R, T89S, T89Y, S92A, S92C, S92D, S92E, S92F, S92G, S92H, S92L, S92M, S92N, S92Q, S92R, S92T, S92W, S92Y, N93A, N93C, N93E, N93F, N93H, N93I, N93K, N93L, N93Q, N93S, N93T, N93Y, G94A, G94C, G94N, I95M, Q96A, Q96E, Q96H, Q96I, Q96K, Q96L, Q96M, Q96N, Q96R, Q96V, Q96Y, V97I, V97T, Y98F, Y98I, Y98L, Y98V, V101C, V101T, G108A, G108S, Y111D, Y111E, Yl 11L, Yl 1 IN, Yl 1 IS, Yl 1 IT, Yl 1 IV, Tl 12A, Tl 12F, Tl 12H, Tl 121, Tl 12K, Tl 12L, T112M, T112N, T112P, T112R, T112V, T112W, E113D, E113N, E113Q, E113T, N114A, N114C, N114D, N114E, N114F, N114G, N114H, N114I, N114L, N114P, N114Q, N114R, N114S, N114T, N114V, N114W, N114Y, V115A, VI 151, T116A, T116C, T116D, T116G, T116H, T116I, T116K, T116N, T116P, T116Q, T116R, T116S, A117C, A117I, A117S, A117V, V118A, V118C, V118E, V118F, V118H, V118I, V118L, V118M, V118N, V118Q, V118R, V118S, V118W, V118Y, V120A, V120C, V120I, V120M, V120T, P122A, P122D, P122E, P122G, P122H, P122N, P122R, P122S, P122T, P122W, S123A, S123C, S123G, S123K, S123L, N124A, N124D, N124F, N124G, N124L, N124R, N124S, N124V, Y126A, Y126C, Y126D, Y126E, Y126G, Y126H, Y126I, Y126K, Y126L, Y126M, Y126N, Y126Q, Y126R, Y126S, Y126T, Y126V, Y126W, Q127A, Q127C, Q127D, Q127E, Q127F, Q127H, Q127I, Q127K, Q127L, Q127M, Q127N, Q127R, Q127S, Q127T, Q127V, Q127W, Q127Y, T129A, T129C, T129D, T129E, T129F, T129G, T129I, T129K, T129L, T129M, T129N, T129Q, T129R, T129S, T129V, T129W, T129Y, S130A, S130G, S130I, S130K, S130L, S130M, S130N, S130P, S130R, S130T, S130V, S130W, G131A, G131C, G131D, G131F, G131H, G131I, G131K, G131L, G131M, G131P, G131Q, G131V, G131W, G131Y, E132A, E132C, E132D, E132F, E132G, E132H, E132I, E132K, E132L, E132M, E132N, E132P, E132Q, E132R, E132V, E132W, Y133A, Y133D, Y133E, Y133G, Y133K, Y133L, Y133M, Y133R, Y133S, Y133T, Y133W, N134A, N134D, N134F, N134G, N134H, N134I, N134K, N134L, N134M, N134R, N134S, N134V, N134W, N134Y, Q136A, Q136C, Q136D, Q136E, Q136F, Q136H, Q136K, Q136L, Q136M, Q136N, Q136R, Q136S, Q136T, Q136V, Q136W, Q136Y, A137S, A137T, A137V, W138F, W138Y, G140A, G140M, N142F, N142K, N142L, N142M, N142P, N142V, N142W, N142Y, F143H, F143Y, P144C, P144D, P144E, P144G, P144H, P144I, P144K, P144L, P144M, P144N, P144Q, P144S, P144T, P144Y, G147A, G147C, G147H, G147K, G147L, G147M, G147N, G147Q, G147R, T148A, T148D, T148E, T148F, T148I, T148K, T148L, T148R, T148S, T148V, T148W, T149A, T149C, T149D, T149E, T149F, T149H, T149K, T149L, T149M, T149N, T149Q, T149V, T149W, T149Y, Y150H, S151A, S151E, S151F, S151H, S151I, S151K, S151L, S151M, S151Q, S151R, S151V, N152A, N152C, N152D, N152E, N152G, N152H, N152K, N152M, N152P, N152Q, N152R, N152S, N152T, W153F, W153H, W153Q, W153R, W153T, W153Y, K154A, K154C, K154D, K154E, K154G, K154I, K154L, K154M, K154N, K154R, K154T, K154Y, W155P, Q156A, Q156D, Q156E, Q156F, Q156G, Q156H, Q156I, Q156L, Q156M, Q156N, Q156R, Q156S, Q156Y, F158C, F158D, F158K, F158L, F158M, F158N, F158P, F158Q, F158R, F158S, F158V, H159M, H159Y, W165C, W165D, W165E, W165F, W165H, W165I, W165K, W165L, W165M, W165Q, W165R, W165T, W165Y, Q167A, Q167D, Q167E, Q167G, Q167H, Q167K, Q167M, Q167N, Q167P, Q167S, Q167T, Q167V, S168A, S168D, S168F, S168H, S168I, S168K, S168M, S168N, S168Q, S168R, S168T, S168V, S168W, S168Y, S170A, S170C, S170D, S170E, S170F, S170L, S170M, S170N, S170Q, S170R, S170T, L171A, L171C, L171F, L171G, L171H, L171I, L171N, L171Q, L171R, L171T, L171V, L171W, L171Y, S172A, S172D, S172H, S172R, S172T, F175M, F175Y, K176I, K176T, F177L, F177V, F177W, D180A, D180C, D180F, D180G, D180H, D180I, D180L, D180M, D180N, D180Q, D180R, D180S, D180T, D180V, D180W, D180Y, G181A, G181C, G181D, G181E, G181F, G181H, G181K, G181L, G181M, G181N, G181Q, G181R, G181S, G181T, G181V, G181Y, K182A, K182P, E187D, E187I, E187K, E187M, E187N, E187P, E187R, E187S, E187T, E187V, E187Y, S190A, S190C, S190D, S190F, S190L, S190N, S190P, S190Q, E191A, E191C, E191F, E191G, E191H, E191I, E191K, E191N, E191Q, E191R, E191S, E191T, E191W, E191Y, G193A, G193C, G193D, G193E, G193F, G193H, G193K, G193L, G193M, G193N, G193Q, G193R, G193S, G193T, G193V, G193W, M199L, Y200F, A201M, Y203I, Y203L, Y203V, D206A, D206E, D206G, D206H, D206M, D206N, D206Q, D206R, D206S, D206T, P208A, P208E, P208F, P208I, P208K, P208L, P208T, P208V, P208Y, V210A, V210E, V210H, V210K, V210N, V210Q, V210R, V210S, V210T, V211A, V211E, V211H, V211I, V211Q, V211R, N212E, N212F, N212G, N212L, N212M, N212R, N212V, M214I, M214L, K215C, K215E, K215F, K215M, K215N, K215R, K215Y, K216F, V219I, V219T, Y221F, Y221I, Y221L, N223C, N223E, N223I, N223K, N223Q, N223R, N223S, N223T, N223V, N223W, N223Y, V225A, V225I, V225L, V225M, G226D, G226M, G226Q, G226R, G226S, L227F, L227I, L227W, L227Y, V235A, I238A, I238L, I238M, K239D, K239E, K239P, K239Q, K239R, K239S, K239T, F240K, F240L, F240M, F240Q, F240R, Q241A, Q241C, Q241D, Q241E, Q241G, Q241H, Q241K, Q241L, Q241M, Q241N, Q241P, Q241R, Q241S, Q241T, Q241V, Q241W, Q241Y, F242V, L243C, L243Y, D245A, D245C, D245E, D245G, D245L, D245M, D245N, W246F, V247I, V247L, D248E, D248H, D248N, D248T, D248V, N249A, N249E, N249G, N249H, N249Q, N249Y, A250M, A250S, A250V, A252C, A252D, A252E, A252G, A252H, A252I, A252K, A252L, A252M, A252N, A252Q, A252S, A252V, A252W, A252Y, A253E, A253I, A253K, A253L, A253M, A253Q, A253S, A253T, A253V, A253Y, T254F, T254K, T254S, K256A, K256M, K256N, K256S, E257Q, E257S, M258L, T260A, T260C, T260S, T260V, V261I, V261W, G262A, Q266A, Q266D, Q266E, Q266H, Q266I, Q266M, Q266N, Q266S, Q266T, Q266V, Q266Y, N267H, N267I, N267Q, N267R, N267S, N267T, N267V, N267Y, D268G, D268N, L269C, L269D, L269I, L269K, L269Q, L269S, L269T, L269Y, G270A, G270D, G270E, G270F, G270H, G270I, G270L, G270M, G270Q, G270T, G270V, G270Y, A271C, A271D, A271E, A271H, A271K, A271M, A271Q, A271R, A271S, A271T, A271V, A271Y, N273C, N273G, N273H, N273I, N273K, N273R, L276I, L276M, A277C, A277D, A277E, A277F, A277G, A277I, A277K, A277L, A277M, A277N, A277Q, A277R, A277S, A277T, A277V, A277W, A277Y, V279C, V279T, N280A, N282S, N282T, S284T, S284Y, L285A, L285C, L285I, L285V, F286M, A288C, A296C, A296D, A296E, A296F, A296G, A296H, A296I, A296L, A296M, A296N, A296Q, A296R, A296S, A296V, A296W, A296Y, T299A, T299D, T299E, T299F, T299G, T299K, T299L, T299M, T299R, T299S, T299V, T299W, G300A, G300C, G300D, G300E, G300F, G300H, G300K, G300M, G300Q, G300R, G300V, G300W, G301A, G301C, G301D, G301E, G301F, G301H, G301K, G301L, G301M, G301Q, G301R, G301S, G301T, G301V, G301W, G301Y, G302S, Y303A, Y303C, Y303D, Y303E, Y303F, Y303G, Y303H, Y303I, Y303K, Y303L, Y303M, Y303N, Y303Q, Y303R, Y303S, Y303T, Y303V, Y303W, Y304F, Y304K, Y304W, R307A, R307C, R307E, R307G, R307H, R307K, R307M, R307N, R307Q, R307S, R307T, N308C, N308D, N308E, N308G, N308L, N308M, N308T, N308V, L310A, L310C, L310D, L310E, L310H, L310I, L310M, L310P, L310W, L310Y, N311C, N311E, N311G, N311H, N311K, N311Q, N311R, N311S, N311V, N311W, N311Y, N312D, N312F, N312G, N312H, N312K, N312Q, N312R, T313A, T313S, A316D, A316E, A316G, A316H, A316K, A316Q, A316R, A316Y, S317C, S317D, S317G, S317H, S317K, S317L, S317N, S317Q, S317R, S317T, S317W, S317Y, N318A, N318C, N318F, N318G, N318I, N318K, N318L, N318M, N318Q, N318R, N318S, N318T, N318V, N318W, T320A, T320C, T320D, T320E, T320G, T320H, T320I, T320K, T320N, T320P, T320Q, T320R, T320V, T320W, T320Y, K321C, K321F, K321H, K321N, K321S, K321Y, L325A, L325C, L325F, L325I, L325M, L325Q, L325V, E327D, E327L, Q335C, Q335E, E338A, E338D, E338F, E338G, E338H, E338I, E338K, E338P, E338Q, E338R, E338T, E338V, E338Y, Q342A, Q342C, Q342G, Q342L, Q342M, Q342R, Q342S, Q342T, Q342V, Q342W, L348A, L348C, L348H, L348I, L348M, L348Q, L348S, L348T, A349G, A349R, F352I, F352L, F352M, F352T, F352V, R356Q, S357A, S357C, S357D, S357E, S357F, S357H, S357I, S357K, S357L, S357N, S357Q, S357T, S357V, S357W, S357Y, Y360F, Y360I, Y360L, Y360M, Y360V, S362A, S362C, S362E, S362I, S362T, S362V, V363I, V363L, M368F, M368I, M368L, M368Y, Y369A, Y369E, Y369I, Y369L, Y369N, Y369V, R377A, R377C, R377D, R377E, R377F, R377G, R377H, R377I, R377K, R377L, R377N, R377Q, R377S, R377T, R377V, R377W, R377Y, A381C, A381E, A381G, A381H, A381K, A381L, A381M, A381N, A381P, A381Q, A381V, A381W, A381Y, L382F, L382H, L382Q, L382S, K383A, K383C, K383D, K383E, K383H, K383I, K383L, K383M, K383N, K383Q, K383R, K383S, K383W, K383Y, S384A, S384C, S384D, S384F, S384G, S384H, S384I, S384L, S384N, S384R, S384V, S384Y, K385A, K385D, K385E, K385F, K385G, K385H, K385L, K385M, K385Q, K385R, K385T, K385V, K385Y, P388A, P388C, P388D, P388I, P388L, P388N, P388R, P388S, P388T, P388V, L390M, L390V, A392C, A392S, K394A, K394C, K394E, K394F, K394G, K394H, K394I, K394L, K394Q, K394R, K394S, K394T, K394V, K394W, K394Y, D395A, D395E, D395N, D395S, D395T, Y396A, Y396D, Y396F, Y396K, Y396M, Y396N, Y396Q, Y396T, Y396V, Y396W, A397D, A397E, A397H, A397K, A397M, A397N, A397Q, A397V, Y398A, Y398C, Y398F, Y398H, Y398I, Y398L, Y398W, T400A, T400C, T400D, T400F, T400G, T400I, T400K, T400L, T400M, T400N, T400Q, T400R, T400W, T400Y, Q401A, Q401C, Q401F, Q401H, Q401I, Q401L, Q401M, Q401N, R402C, R402D, R402F, R402K, R402L, R402M, R402N, R402Q, R402S, R402W, D403E, D403N, D403S, Y404E, Y404G, Y404K, Y404M, Y404N, Y404R, Y404W, I405C, I405F, I405L, I405M, I405V, N407A, N407C, N407D, N407E, N407G, N407K, N407M, N407Q, N407R, P408A, P408C, P408D, P408I, P408K, P408L, P408M, P408N, P408Q, P408V, P408W, V410A, V410C, V410D, V410E, V410F, V410H, V410I, V410L, V410M, V410N, V410Q, V410S, V410T, T414A, T414I, T414S, T414V, R415M, E416C, E416D, E416F, E416H, E416I, E416K, E416L, E416M, E416N, E416Q, E416R, E416T, E416V, E416W, E416Y, D418A, D418E, D418G, D418H, D418I, D418K, D418L, D418M, D418N, D418Q, D418S, D418T, D418V, D418W, S419A, S419C, S419E, S419G, S419L, S419M, S419N, S419R, S419V, S419W, S419Y, T420A, T420C, T420D, T420E, T420G, T420H, T420I, T420K, T420M, T420P, T420S, T420V, T420W, T420Y, K421A, K421D, K421E, K421H, K421I, K421L, K421M, K421N, K421P, K421Q, K421R, K421T, K421V, K421W, K421Y, A422C, A422D, A422E, A422F, A422G, A422I, A422L, A422N, A422P, A422Q, A422R, A422S, A422Y, K423A, K423D, K423E, K423F, K423H, K423I, K423L, K423M, K423N, K423Q, K423R, K423S, K423T, K423V, K423W, K423Y, S424A, S424C, S424G, S424K, S424N, S424Q, S424R, S424T, L426S, L426T, L426V, T428G, T428V, V429A, V429C, V429I, V429L, I430C, I430G, I430L, I430M, I430Q, I430V, T431A, T431C, T431S, P434A, P434C, P434D, P434E, P434F, P434H, P434I, P434K, P434L, P434M, P434N, P434Q, P434R, P434S, P434V, P434Y, G435A, G435C, G435D, G435E, G435F, G435H, G435I, G435K, G435M, G435N, G435P, G435Q, G435R, G435S, G435T, G435W, G436F, G436I, G436M, G436N, G436Q, G436S, G436V, R439A, R439D, R439G, R439H, R439K, R439M, R439N, R439P, R439Q, R439S, R439V, R439W, R439Y, Y441A, Y441C, Y441D, Y441F, Y441G, Y441H, Y441K, Y441L, Y441M, Y441N, Y441P, Y441R, Y441S, Y441T, Y441W, V442A, V442C, V442I, V442T, T444C, T444D, T444E, T444F, T444G, T444H, T444I, T444K, T444L, T444M, T444N, T444P, T444R, T444S, T444W, S445A, S445C, S445E, S445G, S445H, S445K, S445L, S445M, S445N, S445T, S445V, N446A, N446C, N446H, N446K, A447C, A447D, A447F, A447H, A447L, A447M, A447N, A447Q, A447R, A447S, A447Y, G448A, G448C, G448D, G448E, G448H, G448K, G448L, G448M, G448N, G448Q, G448R, G448S, G448T, G448W, E449D, E449H, E449K, E449T, I450A, I450C, I450D, I450E, I450G, I450K, I450L, I450M, I450N, I450Q, I450S, I450T, I450W, I450Y, W451Y, L454A, L454I, L454K, L454M, L454W, T455A, T455I, T455L, T455S, N457H, N457K, N457R, N457T, N457V, N457Y, D460A, D460E, D460G, D460M, D460N, D460Q, D460S, D460V, K461C, K461H, K461L, K461M, K461N, K461Q, K461T, K461Y, I462A, I462L, I462M, I462Q, I462T, I462V, T463D, T463E, T463H, T463P, T463Q, T463R, T463V, T463Y, I464P, I464T, G465A, G465C, G465D, G465E, G465K, G465L, G465M, G465N, G465Q, G465W, G465Y, S466A, S466C, S466D, S466G, S466H, S466K, S466L, S466M, S466N, S466T, S466W, S466Y, D467E, D467G, D467L, Y469A, Y469D, Y469E, Y469I, Y469M, Y469N, Y469R, Y469S, Y469T, Y469V, Y469W, A470S, A470V, T471A, T471C, T471E, T471G, T471H, T471I, T471L, T471M, T471N, T471S, T471V, T471W, P473C, P473D, P473E, P473G, P473I, P473K, P473L, P473R, P473T, P473W, V474A, V474C, V474L, V474S, N475A, N475C, N475E, N475F, N475H, N475K, N475L, N475M, N475P, N475Q, N475R, N475S, N475T, N475V, G476A, G476D, G476E, G476F, G476H, G476I, G476L, G476M, G476N, G476P, G476Q, G476R, G476S, G476T, G476V, G476W, G476Y, G477A, G477D, G477F, G477H, G477I, G477K, G477L, G477M, G477Q, G477S, G477T, G477V, G477W, G477Y, V479C, V479D, V479E, V479F, V479H, V479I, V479N, V479P, V479Y, S480A, S480C, S480H, V481A, V481C, V481N, W482Y, V483A, V483G, V483I, V483K, V483L, V483M, V483R, V483Y, Q484A, Q484C, Q484F, Q484G, Q484H, Q484K, Q484L, Q484M, Q484P, Q484R, Q484T, and Q484Y.
[0074] In all cases, corresponding amino acid positions in other a-amylases be identified by amino acid sequence alignment with CspAmy2 (SEQ ID NO: 1) using Clustal W with default parameters. Preferred CspAmy2 variants produce at least as much DP5, in absolute or relative amounts, as the parental CspAmy2 a-amylase, and/or demonstrate a further performance benefit, as described, herein. In some embodiments, the CspAmy2 variants produce more DP5, in absolute or relative amounts, compared to the parental CspAmy2 a- amylase.
[0075] The present amylases may include any number of conservative amino acid
substitutions. Exemplary conservative amino acid substitutions are listed in Table 1.
Table 1. Conservative amino acid substitutions
Figure imgf000022_0001
Figure imgf000023_0001
[0076] The reader will appreciate that some of the above-mentioned conservative mutations can be produced by genetic manipulation, while others are produced by introducing synthetic amino acids into a polypeptide by genetic or other means.
[0077] The present amylase may be "precursor," "immature," or "full-length," in which case they include a signal sequence, or "mature," in which case they lack a signal sequence. Mature forms of the polypeptides are generally the most useful. Unless otherwise noted, the amino acid residue numbering used herein refers to the mature forms of the respective amylase polypeptides. The present amylase polypeptides may also be truncated to remove the N or C-termini, so long as the resulting polypeptides retain amylase activity.
[0078] The present amylase may be a "chimeric" or "hybrid" polypeptide, in that it includes at least a portion of a first amylase polypeptide, and at least a portion of a second amylase polypeptide (such chimeric amylases have recently been "rediscovered" as domain-swap amylases). The present amylases may further include heterologous signal sequence, an epitope to allow tracking or purification, or the like. Exemplary heterologous signal sequences are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA.
4. Starch Substrates
[0079] The following section describes the selection and preparation of starch substrates. 4.1. Selection of Starch Substrates
[0080] A useful starch substrate may be obtained from tubers, roots, stems, legumes, cereals or whole grain. More specifically, the granular starch may be obtained from e.g., corn, cobs, wheat, barley, rye, triticale, milo, sago, millet, cassava, tapioca, sorghum, rice, peas, bean, banana, or potatoes. Corn contains about 60-68% starch; barley contains about 55-65% starch; millet contains about 75-80% starch; wheat contains about 60-65% starch; and polished rice contains 70-72% starch. Specifically contemplated starch substrates are corn starch and wheat starch. The starch from a grain may be ground or whole and includes corn solids, such as kernels, bran and/or cobs. The starch may also be highly refined raw starch or feedstock from starch refinery processes. Various starches also are commercially available. For example, corn starch is available from Cerestar, Sigma, and Katayama Chemical Industry Co. (Japan); wheat starch is available from Sigma; sweet potato starch is available from Wako Pure Chemical Industry Co. (Japan); and potato starch is available from Nakaari Chemical Pharmaceutical Co. (Japan).
[0081] The starch substrate can be a crude starch from milled whole grain, which contains non-starch fractions, e.g., germ residues and fibers. Milling may comprise either wet milling or dry milling or grinding. In wet milling, whole grain is soaked in water or dilute acid to separate the grain into its component parts, e.g., starch, protein, germ, oil, kernel fibers. Wet milling efficiently separates the germ and meal (i.e., starch granules and protein) and is especially suitable for production of syrups. In dry milling or grinding, whole kernels are ground into a fine powder and often processed without fractionating the grain into its component parts. In some cases, oils from the kernels are recovered. Dry ground grain thus will comprise significant amounts of non-starch carbohydrate compounds, in addition to starch. Dry grinding of the starch substrate can be used for production of ethanol and other biochemicals. The starch substrate can also be from a direct starch to sugar process, a raw or granular starch hydrolysis process. The starch substrate can also be a hydrolyzed form of starch, such as maltodextrin. The starch substrate to be processed may optionally be refined and may be, for example, at least 90%, at least 95%, at least 97%, or at least 99.5% pure.
4.2. Gelatinization, Liquefaction and Saccharification of Starch
[0082] Liquefaction refers to a process by which starch is converted to less viscous and shorter chain carbohydrates. Generally, this process involves gelatinization of starch simultaneously with or followed by the addition of a-amylase, although additional enzymes may optionally be added to affect liquefaction. In some embodiments, the starch substrate as described above is slurried with water. The starch slurry may contain starch at a dry solid content of about 10-55%, about 20-45%, about 30-45%, about 30-40%, or about 30-35%. <x- amylase may be added to the slurry, with a metering pump, for example. To optimize a- amylase stability and activity, the pH of the slurry typically is adjusted to about pH 5.5 - 6.5 and about 1 mM of calcium (about 40 ppm free calcium ions) can also be added. Bacterial a- amylase remaining in the slurry following liquefaction may be deactivated via a number of methods known in the art.
[0083] The slurry of starch plus the a-amylase may be pumped continuously through a jet cooker, which is steam heated to about 105-110°C. Gelatinization occurs rapidly under these conditions, and the enzymatic activity, combined with the significant shear forces, begins the hydrolysis of the starch substrate. The residence time in the jet cooker is brief. The partly gelatinized starch may be passed into a series of holding tubes maintained at about 105- 110°C and held for 5-8 min. to complete the gelatinization process (i.e., "primary
liquefaction"). Secondary liquefactoin is performed in holding tanks at 85-95°C or higher temperatures for about 1 to 2 hours . These tanks may contain baffles to discourage back mixing. The slurry is then allowed to cool, typically to about 60-64° or even to room temperature. Starch processing may in some cases also be conducted entirely below the gelatinizing temperature of starch. The liquefied starch typically is in the form of a slurry having a dry solids content (w/w) of about 10-50%; about 10-45%; about 15-40%; about 20- 40%; about 25-40%; or about 28-38%.
[0084] Liquefaction with a-amylases advantageously can be conducted at low pH, eliminating the requirement to adjust the pH to about pH 5.5 - 6.5. a-amylases can be used for liquefaction at a pH range of 2.0 - 7.0, e.g., pH 3.0 - 7.5, pH 4.0 - 6.0, or pH 4.5 - 5.8. <x- amylases can maintain liquefying activity at a temperature range of about 85°C - 95°C, e.g., 85°C, 90°C, or 95°C. For example, secondary liquefaction can be conducted with a solution of 25% DS corn starch for 10 min at pH 5.8 and 85°C, or pH 4.5 and 95°C. Liquefying activity can be assayed using any of a number of known assays in the art.
[0085] Saccharification refers to a process by which a starch substrate produced in liquefaction, also called liquefact, or a starch substrate generated through granular starch hydrolysis, is further hydrolysed into a specialty syrup or into glucose. Those skilled in the production of syrups and glucose are able to optimize the conditions of saccharification depending on the desired end-product. Enzymes used for saccharification include a- amylases, β-amylases, glucoamylases, pullulanases, and maltogenic amylases, depending on the desired end product. The pH may vary between 4.0 - 6.0 and the temperature between 55 - 70°C, for example, 58 - 64°. The process is typically carried out for at least 6, at least 12, at least 24, at least 36, at least 48, at least 60, at least 72, at least 84, or even at least 96 hours.
[0086] Although the conditions of saccharification greatly affect the characteristics of the final syrup, the properties of the enzymes are also important. Particularly where it is desirable for the end product to be a specialty syrup containing a large amount of particular oligosaccharides, such as DP5 (as opposed to mainly glucose), the enzymatic properties of the a-amylase have a significant effect on the final syrup.
[0087] All references cited herein are herein incorporated by reference in their entirety for all purposes. In order to further illustrate the compositions and methods, and advantages thereof, the following specific examples are given with the understanding that they are illustrative rather than limiting.
EXAMPLES
Example 1
[0088] In a bench-scale saccharification experiment duplicate samples of 20 g of corn starch liquefact with a DS of 30% and DE of 11.6 were incubated in the presence of α-amylase at 60°C, pH 5.2, for up to 30 hours. The α-amylase used was either a commercially available Bacillus α-amylase product {i.e., OPTIMASE® AA 56L, PURASTAR® HP Am 5000L, SPEZYME® XTRA, SPEZYME® ALPHA PF, or SPEZYME® FRED (all from DuPont Industrial Biosciences (Palo Alto, California, USA) or CspAmy2-vl (SEQ ID NO: 2). The commercially available products were dosed at 0.2 kg/MT DS. CspAmy2-vl was dosed at 0.006 mg/g DS. The target amount of enzyme in the corn starch liquefact was typically about 0.006 mg/g DS. Since the size distribution of starch hydrolysis products is primarily a feature of the α-amylase rather than the concentration of the a-amylase, minor differences in the final concentration of α-amylase were not considered to be important. The concentrations of each α-amylase used are shown in Table 2. Table 2. α-amylases used for proces
Figure imgf000027_0001
[0089] Samples of the syrup were taken over time during the 30 hrs incubation. The samples were lOx diluted with demineralized water and boiled for 10 minutes to kill enzyme activity and were filtered with a 0.22 μιη filter before measuring them with a HPLC system
(Shimadzu) using a column specialized for DPI- 10 sugars, namely Aminex HPx-42A (Bio- Rad) as described in Messaoud, E.B. et al. (2004) Enzyme and Microbial Technology 34:662-666. The following analysis conditions were used: column temperature 85°C, ultrapure water as eluens, flow rate of 0.6 ml/min, injection volume of 20 μΐ, and a RI detector with cell temperature of 40°C. The oligosaccharide profile produced by the various tested a-amylases over time are shown in the graphs in Figures 1-6. The amount of DP5 produced over time by CspAmy2, PURASTAR® HP Am 5000L, and OPTIMASE® AA 56L is shown in more detail in Figure 7.
[0090] In general, all the a-amylases tested produced DP2, DP3, DP5, and DP6 as the main oligosaccharide products. However, the oligosaccharide profile produced by CspAmy2 was unique. In particular, after 30 hours incubation:
(i) DP6/DP5 was 0.11 using CspAmy2 while being >0.49 using the other tested a- amylases;
(ii) DP4/DP5 was 0.21 using CspAmy2 while being >0.28 using the other tested a- amylases;
(iii) DP3/DP5 was 0.61 using CspAmy2 while being >0.71 using the other tested a- amylases;
(iv) DP2/DP5 was 0.36 using CspAmy2 while being >0.51 using the other tested a- amylases;
(v) DP1/DP5 was 0.24 using CspAmy2 while being 0.12 - 0.18 using the other tested a- amylases; and
(vi) the DPI concentration was higher using CspAmy2 than using the other tested a- amylases (which could be explained by the hydrolysis of DP6 into DP5 and DPI). [0091] Overall, CspAmy2 produced a much purer DP5 syrup than any of the other tested a- amylases, with >30 DP5 and <10 DP6 as fractions of total reaction products.
Example 2
[0092] In a similar experiment, the amounts of DP6, DP5, DP3, and DP2 were measured after treating maltodextrin with a DE of 7.4 (Sigma Aldrich) in a 30% DS solution with varying amounts of CspAmy2-vl (i.e., 3, 6, or 9 μg/g DS). As shown in the graph in Figure 8, while starch hydrolysis is slower using decreasing amounts of enzyme, the signature oligosaccharide profile produced by CspAmy2 remains the same.
[0093] Although the foregoing compositions and methods have been described in some detail by way of illustration and examples for purposes of clarity of understanding, it will be apparent to those skilled in the art that certain changes and modifications may be made. Therefore, the description should not be construed as limiting the scope of the invention, which is delineated by the appended claims.
[0094] All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entireties for all purposes and to the same extent as if each individual publication, patent, or patent application were specifically and individually indicated to be so incorporated by reference.

Claims

CLAIMS What is claimed is:
1. A non-naturally-occurring syrup produced from a starch substrate by incubation with an a-amylase, comprising >30 DP5 and <10% DP6 as fractions of total reaction products or DP6/DP5 <0.30, DP3/DP5 <0.70, and DP2/DP5 <0.50.
2. The syrup of claim 1, having a concentration ratio of DP6/DP5 <0.30.
3. The syrup of claim 2, having a concentration ratio of DP6/DP5 <0.20.
4. The syrup of claim 3, having a concentration ratio of DP6/DP5 <0.15.
5. The syrup of any of claims 1-4, produced by incubating a starch substrate in the presence of CspAmy2 a-amylase or a variant, thereof.
6. The syrup of claim 5, wherein the α-amylase is a variant of CspAmy2 comprising a deletion of residues 178 and 179 or 180 and 181, using SEQ ID NO: 3 for numbering.
7. A method for producing a syrup from a starch substrate, comprising incubating the starch substrate in the presence of an α-amylase capable of producing >30 DP5 and <10% DP6 as fractions of total reaction products, or DP6/DP5 <0.30, DP3/DP5 <0.70, and
DP2/DP5 <0.50, in a period of 30 hours at pH 5.2 and 60°C.
8. The method of claim 7, wherein the α-amylase is capable of producing a reaction product having a concentration ratio of DP6/DP5 <0.30 in a period of 30 hours at pH 5.2 and 60°C.
9. The method of claim 8, wherein the α-amylase is capable of producing a reaction product having a concentration ratio of DP6/DP5 <0.20 in a period of 30 hours at pH 5.2 and 60°C.
10. The method of claim 9, wherein the α-amylase is capable of producing a reaction product having a concentration ratio of DP6/DP5 <0.15 in a period of 30 hours at pH 5.2 and 60°C.
11. The method of any of claims 7-10, wherein the starch substrate is a corn, cereal, grain, or tuber liquifact.
12. The method of any of claims 7-11, wherein the starch substrate comprises from about 10% to about 40% dissolved solids.
13. The method of any of claims 7-12, wherein the amount of a-amylase used is from about 0.001 to about 0.05 mg/g dissolved solids.
14. The method of any of claims 7-13, wherein incubating the starch substrate in the presence of α-amylase is performed without the addition of calcium to the starch substrate.
15. The method of any of claims 7-14, wherein incubating the starch substrate in the presence of CspAmy2 α-amylase or a variant, thereof, is performed at a pH <7.0.
16. The method of any of claims 7-15, wherein incubating the starch substrate in the presence of α-amylase is performed at a pH <6.0.
17. The method of any of claims 7-15, wherein the starch substrate is incubated in the presence of CspAmy2 α-amylase or a variant, thereof.
18. The method of claim 17, wherein the α-amylase is a variant of CspAmy2 comprising a deletion of residues 178 and 179 or 180 and 181, using SEQ ID NO: 3 for numbering.
19. A syrup produced by the method of any of claims 7-18.
PCT/US2015/048107 2014-09-02 2015-09-02 Dp5-enriched syrups WO2016036834A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462044583P 2014-09-02 2014-09-02
US62/044,583 2014-09-02

Publications (1)

Publication Number Publication Date
WO2016036834A1 true WO2016036834A1 (en) 2016-03-10

Family

ID=54197048

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/048107 WO2016036834A1 (en) 2014-09-02 2015-09-02 Dp5-enriched syrups

Country Status (1)

Country Link
WO (1) WO2016036834A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112368394A (en) * 2018-05-04 2021-02-12 丹尼斯科美国公司 Simplified process for producing maltodextrins and specialty syrups
WO2023150406A1 (en) * 2022-02-03 2023-08-10 Corn Products Development, Inc. Low sugar low viscosity sugar syrup
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287826B1 (en) * 1998-03-09 2001-09-11 Novo Nordisk A/S Enzymatic preparation of glucose syrup from starch
EP1153960A1 (en) * 2000-05-09 2001-11-14 Roquette Frˬres Process for producing a solid shaped form from low DE starch hydrolysates and/or coated with these starch hydrolysates
WO2006136161A2 (en) * 2005-06-24 2006-12-28 Novozymes A/S Amylases for pharmaceutical use
US20120231150A1 (en) * 2011-03-08 2012-09-13 Tate & Lyle Ingredients Americas, LLC Digestive Enzyme Inhibitor and Methods of Use
WO2015077576A1 (en) * 2013-11-24 2015-05-28 E. I. Du Pont De Nemours And Company High force and high stress destructuring for starch biomass processing

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287826B1 (en) * 1998-03-09 2001-09-11 Novo Nordisk A/S Enzymatic preparation of glucose syrup from starch
EP1153960A1 (en) * 2000-05-09 2001-11-14 Roquette Frˬres Process for producing a solid shaped form from low DE starch hydrolysates and/or coated with these starch hydrolysates
WO2006136161A2 (en) * 2005-06-24 2006-12-28 Novozymes A/S Amylases for pharmaceutical use
US20120231150A1 (en) * 2011-03-08 2012-09-13 Tate & Lyle Ingredients Americas, LLC Digestive Enzyme Inhibitor and Methods of Use
WO2015077576A1 (en) * 2013-11-24 2015-05-28 E. I. Du Pont De Nemours And Company High force and high stress destructuring for starch biomass processing

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
C.-L. JEANG ET AL: "Cloning of a Gene Encoding Raw-Starch-Digesting Amylase from a Cytophaga sp. and Its Expression in Escherichia coli", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 68, no. 7, 1 July 2002 (2002-07-01), pages 3651 - 3654, XP055133914, ISSN: 0099-2240, DOI: 10.1128/AEM.68.7.3651-3654.2002 *
JEANG, C-L. ET AL., APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 68, 2002, pages 3651 - 54
MESSAOUD, E.B. ET AL., ENZYME AND MICROBIAL TECHNOLOGY, vol. 34, 2004, pages 662 - 666
MORGAN, F. J.; PRIEST, F.G., J. APPL. BACTERIOL., vol. 50, 1981, pages 107 - 14
OKEMOTO, H. ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 25, 1986, pages 137 - 42
R.-J. SHIAU ET AL: "Improving the Thermostability of Raw-Starch-Digesting Amylase from a Cytophaga sp. by Site-Directed Mutagenesis", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 69, no. 4, 1 April 2003 (2003-04-01), pages 2383 - 2385, XP055208927, ISSN: 0099-2240, DOI: 10.1128/AEM.69.4.2383-2385.2003 *
SAITO, N., ARCH. BIOCHEM. BIOPHYS, vol. 155, 1973, pages 290 - 98
SHIAU, R-J. ET AL., APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 69, 2003, pages 2383 - 85
SHIDA, O. ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 56, 1992, pages 76 - 80
THOMPSON, NUCLEIC ACIDS RES., vol. 22, 1994, pages 4673 - 4680

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112368394A (en) * 2018-05-04 2021-02-12 丹尼斯科美国公司 Simplified process for producing maltodextrins and specialty syrups
WO2023150406A1 (en) * 2022-02-03 2023-08-10 Corn Products Development, Inc. Low sugar low viscosity sugar syrup
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Similar Documents

Publication Publication Date Title
Aiyer Amylases and their applications
US20120135466A1 (en) Production Of Maltotetraose Syrup Using A Pseudomonas Saccharophila Maltotetraohydrolase Variant And A Debranching Enzyme
ES2673940T3 (en) Process to produce fermentation products from starch-containing materials
JP5463146B2 (en) Starch hydrolysis using phytase with alpha-amylase
EP2561083B1 (en) Use of Humicola grisea glucoamylase in an SSF process at neutral pH
WO2008055138A2 (en) Enzymatic hydrolysis of starch
WO2015065978A1 (en) Trehalase in fermentations
CA2415520A1 (en) A process for hydrolyzing starch without ph adjustment
US20130288309A1 (en) Production of maltotetraose syrup using a pseudomonas saccharophila maltotetraohydrolase variant
US8785165B2 (en) Single pH process for starch liquefaction and saccharification for high-density glucose syrups
Hua et al. Enzymes in starch processing
US7579177B2 (en) Alcohol product processes
US20150111259A1 (en) Method for Making High Maltose Syrup
WO2016036834A1 (en) Dp5-enriched syrups
WO2011100161A1 (en) Addition of alpha - glucosidase and cobalt for producing fermentation products from starch
US20150152458A1 (en) Low temperature method for making high glucose syrup
AU2022202136A1 (en) Trehalase in fermentations
WO2018226569A1 (en) Use of betaine to stabilize and/or increase the activity of enzymes in stressful environments
Ray β-amylases from various fungal strains
Jegal et al. Continuous biocatalytic production of trehalose in a fixed-bed bioreactor using immobilized trehalose synthase from Pseudomonas stutzeri
WO2023114814A2 (en) Compositions and methods for producing allulose
WO2023091631A2 (en) High performance alphα-amylases for starch liquefaction
Gohel et al. Industrial enzyme applications in biorefineries for starchy materials
EP3788162A1 (en) Simplified process for producing maltodextrin and specialty syrups
CN114761571A (en) Process for the preparation of fermentable sugar compositions and fermentations thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15770682

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15770682

Country of ref document: EP

Kind code of ref document: A1